{"text": "Of the four patients who relapsed in a previously irradiated site , only one recurred exclusively within a prior treatment field ( dose , 36 Gy ) .", "label": "", "metadata": {}, "score": "23.00114"}
{"text": "Thirty - two patients experienced further relapses , and 13 continued in complete remission after surgical resection of the residual disease .Three - year overall survival was 40 % , and 3-year progression - free survival was 24 % .", "label": "", "metadata": {}, "score": "26.357834"}
{"text": "Analysis of tumor recurrence .One patient ( 7.1 % ) had a marginal miss recurrence at the field border ( 13 Gy ) .In the 3DCRT group , twelve patients ( 48 % ) had in - field recurrences in regions treated with doses between 30 Gy and 56 Gy ( Table 3 ) .", "label": "", "metadata": {}, "score": "29.613598"}
{"text": "There were three complete responses ( 25 % ) leading to further curative treatment ( SCT ) .Treatment failed in the other nine patients , and only one patient was alive at the end of follow - up .", "label": "", "metadata": {}, "score": "31.913076"}
{"text": "Thirty - one patients had subsequent surgery .Among them , 24 underwent wide resection of all localisations , and histological response was good in nine and poor in 22 .", "label": "", "metadata": {}, "score": "32.082825"}
{"text": "6/16 patients failed salvage therapy ( 2 PR and 4 relapses ) , and 2 additional patients died in second CR due to thromboembolic disease and HCV infection , 2 and 29 months after the confirmation of second CR , respectively .", "label": "", "metadata": {}, "score": "34.486572"}
{"text": "One patient achieved an ANC of more than 0.5 ?L by day 30 and a platelet count of more than 20 ?L by day 38 , but the patient died before achieving a platelet count of more than 100 ? L.", "label": "", "metadata": {}, "score": "34.705917"}
{"text": "After achieving a second or third CR , 5/17 patients relapsed within 1 , 3 , 4 , 7 and 34 months .Four of these patients previously had resistant disease .", "label": "", "metadata": {}, "score": "34.85137"}
{"text": "Six patients developed cervical lymph node metastases and/ or local and distant relapse 3 to 18 months after re - irradiation .In one of these patients a salvage lymphonodectomy was successfully performed for nodal relapse .", "label": "", "metadata": {}, "score": "35.336506"}
{"text": "Six patients developed cervical lymph node metastases and/ or local and distant relapse 3 to 18 months after re - irradiation .In one of these patients a salvage lymphonodectomy was successfully performed for nodal relapse .", "label": "", "metadata": {}, "score": "35.336506"}
{"text": "Disease progressed in 2 patients after initial treatment ; 26 patients were in first relapse with a median time from diagnosis to first disease recurrence / progression of 18.2 months , and 17 patients were in further relapse .", "label": "", "metadata": {}, "score": "35.558544"}
{"text": "Herman et al .[ 25 ] reported that the actuarial risk of relapse after a 3-year disease - free interval was 13 % .", "label": "", "metadata": {}, "score": "35.790764"}
{"text": "Four of these 410 patients developed neck recurrences , but only 1 had a lower neck relapse outside the irradiation field .Another study by Tang et al [ 9 ] presented a series of 138 patients who underwent selective irradiation to the upper neck alone ( 37 patients ) or to the entire neck ( 101 patients ) , with no neck relapse in either group .", "label": "", "metadata": {}, "score": "36.04668"}
{"text": "A matched pair analysis was performed including 11 patients of each group .Results .Recurrence analysis showed that in - field local relapses occurred in previously underdosed regions of the tumor bed in 16 % of patients treated with 3DCRT and in 0 % of HCRT patients .", "label": "", "metadata": {}, "score": "36.71667"}
{"text": "In one patient with a regional recurrence ( 4.0 % ) the delivered dose was not possible to define because no diagnostic CT was available .", "label": "", "metadata": {}, "score": "37.094894"}
{"text": "Two patients achieved a partial remission .The median followup was at 32 months ( range : 8 - 250 ) , 6 patients died ( Table 2 ) .", "label": "", "metadata": {}, "score": "37.20112"}
{"text": "Data are missing for 2 patients .Thirty - one patients underwent surgery , 23 had complete resection and eight had partial resection .Eleven patients had a second course of high dose TTP after surgery .", "label": "", "metadata": {}, "score": "37.472897"}
{"text": "Sixteen girls and 29 boys ( median age , 15.9 years ) received HD thiotepa after initial progression of metastatic disease ( 2 ) , first relapse ( 26 ) , and second or third relapse ( 17 ) .", "label": "", "metadata": {}, "score": "38.092587"}
{"text": "Table 2 .Locoregional recurrences in patients who underwent highly conformal modulated radiotherapy .Distant recurrences occurred in ten patients ( 71.4 % ) treated with HCRT and in twenty 3DCRT patients ( 80 % ) .", "label": "", "metadata": {}, "score": "38.178787"}
{"text": "Four patients showed a transient increase of hepatic transaminases ( W.H.O. grade I ) and one patient a reversible hyperbilirubinaemia with a peak serum level of 92mmol / l .", "label": "", "metadata": {}, "score": "38.19329"}
{"text": "Patients were hospitalized in HEPA - filtered rooms , and standard supportive care measures were followed .Two patients received sequential high - dose therapy followed by stem - cell rescue .", "label": "", "metadata": {}, "score": "38.34002"}
{"text": "All patients underwent surgery of the primary tumour .Based on Huvos grading [ 20 ] , histological response to initial chemotherapy was good in 17 patients and poor in 28 .", "label": "", "metadata": {}, "score": "38.546543"}
{"text": "Chen et al [ 15 ] demonstrated that the regional control of 128 patients with node - negative ( N0 ) NPC was 98.2 % with no relapse in the IV and Vb regions , which were omitted during elective node irradiation .", "label": "", "metadata": {}, "score": "38.560654"}
{"text": "Twelve patients achieved CR , seven achieved PR , and five had SD .The main side effects were haematological , with prolonged thrombocytopenia , as well as three patients who developed a myelodysplastic syndrome following treatment [ 24 ] .", "label": "", "metadata": {}, "score": "38.804543"}
{"text": "In a large phase II single arm multicenter study , 102 heavily pretreated patients who relapsed after ASCT were treated using the MTD dose of 1.8 mg / kg administered every 3 weeks .", "label": "", "metadata": {}, "score": "38.913605"}
{"text": "All in - field recurrences were carefully analyzed by 2 of the authors ( JK , PD ) , in order to assess if they occurred in previously underdosed areas by comparing the respective diagnostic image with the radiation therapy treatment plan .", "label": "", "metadata": {}, "score": "39.026566"}
{"text": "All nine patients with detectable cytogenetic abnormalities achieved a second CR and five of them are in continuous CR after BMT / PBSCT ( patients 8 , 9 , 21 , 22 and 23 ) .", "label": "", "metadata": {}, "score": "39.540157"}
{"text": "Six of the 13 patients relapsed more than 2 years after transplantation .Elevenofthe13patientswhorecurreddied from HD , and two patients are alive with disease .There Table 2 .", "label": "", "metadata": {}, "score": "39.653816"}
{"text": "Relapse localisations were isolated lung metastasis in 23 patients , isolated bone site in one , combined lung and another localisation in 15 , and other sites in four .", "label": "", "metadata": {}, "score": "39.84204"}
{"text": "[ 16 ] .The presence of suspicious nodes did not change the node staging , but the corresponding lymphatic drainage level received an additional boost dose of 10 Gy to account for any diagnostic uncertainty .", "label": "", "metadata": {}, "score": "40.00992"}
{"text": "Treatment response and survival All 23 patients were evaluable for response ( Table III .17/23 patients ( 74 % ) achieved a CR , one patient showed a PR , and five patients were nonresponders .", "label": "", "metadata": {}, "score": "40.084896"}
{"text": "[ 18 ] For patients in both groups , the primary tumor , the potentially involved surrounding tissues , and the upper neck lymph drainage areas were irradiated .", "label": "", "metadata": {}, "score": "40.12078"}
{"text": "In all patients who relapsed , a second biopsy was performed to prove the HL histology of relapse .Statistical Analysis .STROBE reporting guidelines for observational studies were followed [ 33 ] .", "label": "", "metadata": {}, "score": "40.578613"}
{"text": "There was no correlation of local control and the interval between primary therapy and re - irradiation or the volume of re - irradiation .In 2 patients persistent ulcers of the oral mucosa occurred .", "label": "", "metadata": {}, "score": "40.69"}
{"text": "There was no correlation of local control and the interval between primary therapy and re - irradiation or the volume of re - irradiation .In 2 patients persistent ulcers of the oral mucosa occurred .", "label": "", "metadata": {}, "score": "40.69"}
{"text": "[ 13 ] .The median overall survival of their 61 patients treated was 14.2 months with a locoregional recurrence rate of 13 % and only 5 % local in - field recurrences reported .", "label": "", "metadata": {}, "score": "41.169994"}
{"text": "Of the 10 patients who had not received any radiation beforetransplantation , fourreceivedfTBIaspartoftheirhigh- dose therapy regimen , five underwent post - transplantation consolidative radiation therapy ( mean dose , 33 Gy ) , and one didnotreceiveanyradiation .", "label": "", "metadata": {}, "score": "41.335365"}
{"text": "[ 6 ] For patients in the WNI group , a lower neck anterior field delivered by a 6-MV photon with a 3-cm central block was used to give a total dose of 50 Gy , regardless of the radiotherapy technique used .", "label": "", "metadata": {}, "score": "41.51866"}
{"text": "In fact , 5/6 patients treated with the same regimen ( 4 MOPP / ABVD to MOPP / ABVD , 2 MOPP / ABVD to ABVD ) achieved a second CR , but 2/5 relapsed , and one is not evaluable for relapse due to early death .", "label": "", "metadata": {}, "score": "41.557953"}
{"text": "Peggs et al . investigated the role of in vivo T depletion in 67 relapsed / refractory HL patients , mostof whom had previously undergone ASCT .", "label": "", "metadata": {}, "score": "41.882374"}
{"text": "Assessment of histological response in 5 cases yielded percentages of viable cells of 0 , 5 , 20 , 20 , and 90 % [ 16 ] .", "label": "", "metadata": {}, "score": "41.92466"}
{"text": "We excluded from analysis 8 patients who received high dose thiotepa as a first - line consolidation treatment for metastatic disease and retrospectively reviewed the medical charts of the 45 remaining patients .", "label": "", "metadata": {}, "score": "42.02568"}
{"text": "Relapse occurred in 151 pts : 135 ( 29.8 % ) within 5 years and 16 over 5 years ( 3.5 % , very late relapses ) .", "label": "", "metadata": {}, "score": "42.100372"}
{"text": "Persistent T - cell depletion with a marked decrease of T - helper cells was documented 5 and 11 months after completion of treatment .With normal numbers of total leucocytes and total lymphocytes in peripheral blood , the absolute T - helper - cell counts were 0\u00b7146\u00d7109/l and 0\u00b7333\u00d7109/l , respectively .", "label": "", "metadata": {}, "score": "42.296448"}
{"text": "Results .Patient Characteristics .We evaluated 45 patients ( 16 female , 29 male ; median age 15.9 years , range from 4 to 31 years ) .", "label": "", "metadata": {}, "score": "42.54921"}
{"text": "Patient Characteristics and Treatment Compliance .From November 2005 to June 2012 , 301 eligible patients were recruited to the study ( 153 in the UNI group and 148 in the WNI group ) .", "label": "", "metadata": {}, "score": "42.677258"}
{"text": "Event - free survival and overall survival in patients with refractory disease , early relapse and late relapse were 35 \u00b1 9 % , 67 \u00b1 11 % , 76 \u00b1 10 % and 48 \u00b1 11 % , 89 \u00b1 7 % and 80 \u00b1 10 % , respectively .", "label": "", "metadata": {}, "score": "42.723827"}
{"text": "Extranodal disease occurred in 1 patient ( 6 % ) .B symptoms were present in 6 patients ( 37 % ) .One patient ( 6 % ) relapsed on the irradiated field ( mediastinal ) ; 5 ( 31 % ) relapsed in sites of bulky disease ; in 6 patients ( 37 % ) , the disease localization was different from the site at diagnosis .", "label": "", "metadata": {}, "score": "43.043907"}
{"text": "The overall response rate was 75 % with 34 % complete remission and 40 % partial remission , and a median PFS and OS of 5.6 months and 22.4 months , respectively .", "label": "", "metadata": {}, "score": "43.19149"}
{"text": "Pretreatment and treatment patient characteristics were tabulated .Frequencies , median values , rangesorpercentagesweredocumented .Withatotalofonly23 cases the use of further statistical methods was limited .", "label": "", "metadata": {}, "score": "43.433926"}
{"text": "Clinical presentation at relapse demonstrated a supradiaphragmatic localization in 6 cases ( 37 % ) , infradiaphragmatic in 8 ( 50 % ) and located on both sides in 2 cases ( 13 % ) .", "label": "", "metadata": {}, "score": "43.43682"}
{"text": "During the follow - up period , there were 42 deaths , 28 relapses , and 29 distant metastases in the 2 groups .The Kaplan - Meier curves for OS are shown in Figure 2 .", "label": "", "metadata": {}, "score": "43.453476"}
{"text": "The response rate among 39 patients receiving GVD for relapse after ASCT was 75 % ( 17 % CR ) , and median event - free survival was 8.5 months .", "label": "", "metadata": {}, "score": "43.695774"}
{"text": "Seven of them are in CCR following BMT or PBSCT with a median duration of 17\u00b75 months ( range 12\u00b75 - 39 months ) .The median duration of overall survival for all 23 patients was calculated up to the last day ?", "label": "", "metadata": {}, "score": "43.89421"}
{"text": "Our results are also similar to those reportedbyWilliamsetal29of81pediatricHDpatientswho underwent AHSCT .With a median follow - up of 36 months , they reported an OS rate of 64 % and a PFS rate of 39 % .", "label": "", "metadata": {}, "score": "43.9843"}
{"text": "18 months ) achieved a CR .7/11 patients ( 64 % ) with resistant disease , defined as induction failure of first - line treatment or relapse within 12 months after diagnosis of AML , achieved a CR .", "label": "", "metadata": {}, "score": "44.08062"}
{"text": "Another report , by the European Organization for Research and Treatment of Cancer [ 22 ] , showed a 3.5 % incidence of very late relapse after a 5-year disease - free interval .", "label": "", "metadata": {}, "score": "44.09302"}
{"text": "All survivors could have surgical resection of all tumour sites .Three - year OS was 40 % ( CI 95 % , 27 to 55 ) , and 5-year OS was 31 % ( CI 95 % , 20 to 46 ) .", "label": "", "metadata": {}, "score": "44.139225"}
{"text": "Nevertheless , survival outcomes were relatively unchanged , as approximately 50 % of all patients undergoing allogeneic SCT after RIC relapsed [ 14 , 15 ] .", "label": "", "metadata": {}, "score": "44.15332"}
{"text": "We reviewed the clinical outcome of 39 consecutive patients treated either with 3DCRT ( 25 patients ) or HCRT ( 11 IMRT patients and 3 VMAT patients ) .", "label": "", "metadata": {}, "score": "44.154167"}
{"text": "Results .After first - line therapy , 452 patients ( 85 % ) achieved complete remission ( CR ) .The distribution of patients and relapse characteristics as a whole , and divided according to type of relapse , are shown in Table 1 .", "label": "", "metadata": {}, "score": "44.227066"}
{"text": "This patient recov- ered without supplemental hematopoietic cell reinfusion , achievedanANCofmorethan1 ?Londay64,and nolongerrequiredplateletsupport7monthsafterAHSCT .Toxicity Early treatment - related mortality occurred in four ( 10%)of41patients .", "label": "", "metadata": {}, "score": "44.615284"}
{"text": "In the matched pair analysis , 11 HCRT and 11 3DCRT patients were matched based on tumor staging , resection status , tumor histology , age and gender ( except one pair were the gender was not matched ) .", "label": "", "metadata": {}, "score": "44.64378"}
{"text": "Between 1992 and 2004 , 53 patients received HD thiotepa ( 900 mg / m 2 ) followed by ASCT in 6 centres .Eight patients were excluded from analysis , and we retrospectively reviewed the clinical radiological and anatomopathological patterns of the 45 remaining patients .", "label": "", "metadata": {}, "score": "45.418343"}
{"text": "\" The prognosis of such children is very poor : three of our patients with newly diagnosed JMML or MDS / AML were refractory to several different induction regimens ; the remaining nine patients were either refractory to reinduction therapy or in second relapse after SCT .", "label": "", "metadata": {}, "score": "46.021935"}
{"text": "Compliance with the protocol was excellent .Overall , 147 of the 153 in the UNI group and 145 of 148 patients in the WNI group received the full dose of radiotherapy as per the protocol ( Fig . 1 ) .", "label": "", "metadata": {}, "score": "46.09844"}
{"text": "Ten patients ( 62%% ) had stage I - II .B symptoms were present in 12 patients ( 75 % ) , and 7 ( 44 % ) had bulky disease .", "label": "", "metadata": {}, "score": "46.544502"}
{"text": "The reason for the comparatively higher local control rate reported by Rice et al . in comparison to our study remains unclear .It may be explained by patient selection and the comparatively short median overall survival of 14.2 months in comparison to 20.8 months in the present series and by the retrospective study design .", "label": "", "metadata": {}, "score": "46.67486"}
{"text": "No significant impact on survival was observed for initial histological response , radiological response to TTP , surgical resection , histological response to TTP , and the number of previous relapses ( Table 3 ) .", "label": "", "metadata": {}, "score": "46.689995"}
{"text": "One of them was reinduced to CR with the IEV regimen and is still in CR with a followup of 24 months , the other three patients died from toxicity during chemotherapy salvage treatment ( 2 from Gram - negative septic shock , 1 of cardiotoxicity ) .", "label": "", "metadata": {}, "score": "46.72099"}
{"text": "In two patients with a second relapse the relapses occurred 2 months after achieving second complete remission .Most of the patients had a very early relapse ( duration of first or second remission was ?", "label": "", "metadata": {}, "score": "46.836693"}
{"text": "An additional patient died of late treatment - related mortality at day ?206 after trans- plantation as a result of sepsis .Sixteen patients ( 39 % ) developed post - AHSCT idio- pathicdiffuselunginjurysyndrome(acutealveolitis , n ? 2 ; diffuse alveolar hemorrhage , n ? 2 ; acute respiratory dis- tress syndrome , n ? 2 ; delayed interstitial pneumonitis , n ? 9 ; and bronchiolitis obliterans , n ?", "label": "", "metadata": {}, "score": "46.88841"}
{"text": "The purpose of this national retrospective study was to evaluate the outcome of patients with recurrent / refractory HL and determine adverse prognostic factors .Median time from end of treatment to relapse was 6 months ( 3 - 56 ) .", "label": "", "metadata": {}, "score": "46.953922"}
{"text": "The documentedsevererenal were associated with septic or pulmonary infections .No persistent cardiomyopathy was seen at a median cumulative equivalent dose of anthracyclines of 580mg / m2(range 280 - 860mg / m2 ) after the treatment with the IDA - FLAG regimen .", "label": "", "metadata": {}, "score": "46.997284"}
{"text": "In this study , outcomes were correlated with donor availability .A total of 122 of patients ( 66 % ) had a suitable donor .", "label": "", "metadata": {}, "score": "47.06271"}
{"text": "According to the bone marrow biopsies taken one month after FLANG regimen , 10 patients ( 40 % ) had responded to treatment .Five patients of the 10 responders underwent successful bone marrow transplantation ( BMT ) .", "label": "", "metadata": {}, "score": "47.073875"}
{"text": "Follow - Up and recurrence analysis .Patients were followed up every three to four months with clinical examinations and CT or PET / CT scans .", "label": "", "metadata": {}, "score": "47.149963"}
{"text": "Objective responses occurred in 16 patients ( 48 % ) .The median duration of failure - free survival was 2.7 months .Grade 3 or 4 toxic effects included neutropenia and thrombocytopenia [ 23 ] .", "label": "", "metadata": {}, "score": "47.40651"}
{"text": "With further followup it was found that 5-year disease - free survival ( DFS ) and OS were 5 % and 24 % , respectively [ 13 ] .", "label": "", "metadata": {}, "score": "47.42038"}
{"text": "In paediatric clinical studies in the late 1970s and the 1980s , complete remissions were reported in 70 - 85 % of patients .15 - 20 % of patients are refractory to firstline induction therapy and one quarter to one third of patients will relapse .", "label": "", "metadata": {}, "score": "47.586884"}
{"text": "Overall , nine patients remain in continuous complete remission with a median duration of 17\u00b75 months ( 9\u00b75 - 39 months ) .The toxicity of the IDA- FLAG courses was more severe than for the FLAG courses with marked neutropenia and thrombocytopenia ( for IDA- FLAG : median 22\u00b75 and 25d respectively ; for FLAG : median 10\u00b75 and 14d respectively ) .", "label": "", "metadata": {}, "score": "47.719368"}
{"text": "The patient has been followed for 2 years to date , and the node remains stable in size .Unfortunately , the patient developed lung metastases 14 months after treatment .", "label": "", "metadata": {}, "score": "47.781475"}
{"text": "Nevertheless , 12 of 45 patients are alive without disease at 10 years , and 5-year OS is either equivalent or higher than in other published series .", "label": "", "metadata": {}, "score": "47.853615"}
{"text": "7 - 16 , 2003 .View at Google Scholar .J. R. Geyer , F. M. Balis , M. D. Krailo et al . , \" A phase II study of thioTEPA in children with recurrent solid tumor malignancies : a Children 's Cancer Group Study , \" Investigational New Drugs , vol .", "label": "", "metadata": {}, "score": "47.91514"}
{"text": "Three patients ( 2 MDS / AML , 1 JMML ) were refractory to first - line treatment , 8 patients with de novo AML were in refractory first relapse , and one patient with de novo AML was in 2nd relapse after stem cell transplantation ( SCT ) .", "label": "", "metadata": {}, "score": "48.00274"}
{"text": "There is no optimal treatment for patients with Fusarium infection ; however , combination antifungal therapy may have benefit without significant toxicity . \" Following the treatment , 17 individuals entered the CR period .", "label": "", "metadata": {}, "score": "48.13008"}
{"text": "Overall , the median duration of second CR was longer than of the first CR ( 13\u00b75 v 10 months ) for all responders .In the absence of post - remission therapy , most patients relapse again within 12 months of achieving a second CR .", "label": "", "metadata": {}, "score": "48.35042"}
{"text": "As a component of their high - dose therapy regimen , nine of 16 patients received BCNU , three of 16 patients received CCNU , and three of 16 patients received fTBI .", "label": "", "metadata": {}, "score": "48.634857"}
{"text": "More than half of children with relapsed or refractory HD can be successfully treated with the combination of high - dose therapy and AHSCT , confirming the efficacy of this approach .", "label": "", "metadata": {}, "score": "48.68521"}
{"text": "In a phase II clinical trial evaluating the safety and efficacy of vorinostat in refractory / relapsed HL , a total of 25 patients were treated with vorinostat at 200 mg given orally twice per day for 14 days every 21-day cycle .", "label": "", "metadata": {}, "score": "48.747364"}
{"text": "L was 12 days ( range , 1 to 31 days ) in 39 assessable patients ( the remaining two patients underwent sequential stem - cell rescue , and thus , engraftment data were evaluated differently ) .", "label": "", "metadata": {}, "score": "49.065285"}
{"text": "Nine patients showed pulmonary involvement with life - threatening or fatal pneumonia in three patients , of whom one patient was a nonresponder and died from progressive disease and another patient developed a lethal Aspergillus sepsis following a second IDA - FLAG course .", "label": "", "metadata": {}, "score": "49.20468"}
{"text": "L was 17 days ( range , 9 to 38 days ) in 37 assessable patients ( two patients had missing data ) .Three patients died after neutrophil engraftment but before platelet recovery more than 20 ? L. The median time to achieve a platelet count of more than 100 ?", "label": "", "metadata": {}, "score": "49.396584"}
{"text": "The authors found that HL patients who experience a very late relapse have a similar survival to patients who are continuously disease - free .The actuarial incidence of very late relapse at 10 and 15 years in early stage patients was 4.8 % and 8.3 % , respectively .", "label": "", "metadata": {}, "score": "49.4091"}
{"text": "Josting et al . reported 5-year freedom - from - treatment failure ( FFTF ) of 28 % in patients receiving either extended - field or involved - field radiotherapy [ 11 ] .", "label": "", "metadata": {}, "score": "49.451195"}
{"text": "Cytogenetic results performed on pretreatment bone marrow samples could be obtained from 16 patients and showed cytogenic abnormalities in nine ( Table II ) .A prognostic favourable cytogenetic abnormality t(9,11 ) was identified in only two patients ( nos . 8 and 23 ) ( Martinez - Climent et al , 1995 ) .", "label": "", "metadata": {}, "score": "49.747353"}
{"text": "The Italian experience in metastatic relapses of osteosarcomas with an association of high dose carboplatin and etoposide showed a progression rate of 24.4 % , with 20 % 3-year OS and 12 % disease - free survival [ 12 ] .", "label": "", "metadata": {}, "score": "49.78602"}
{"text": "The node progressed to 7 mm after observation for another year .The patient refused a fine - needle aspiration , and remains alive with the node .", "label": "", "metadata": {}, "score": "49.84184"}
{"text": "215 - 217 , 1997 .View at Google Scholar \u00b7 View at Scopus . A. Illes , A. Banyai , G. Vadasz , and G. Szegedi , \" Relapse of Hodgkin 's disease after ten years , \" Oncology , vol .", "label": "", "metadata": {}, "score": "49.943897"}
{"text": "The nodal volume needed for prophylactic irradiation in patients with N0 NPC remains controversial .[ 7 ] The only randomized clinical trial concerning this question was reported by Ho et al in 1978 .", "label": "", "metadata": {}, "score": "50.152504"}
{"text": "Other published studies report equivalent survival rates , with reported median survival after relapse between 10 and 17 months [ 2 - 4 , 36 ] .", "label": "", "metadata": {}, "score": "50.194622"}
{"text": "For this analysis , the patients were matched for age , preoperative TNM , R and histology , and sex ( except one pair ) .", "label": "", "metadata": {}, "score": "50.214302"}
{"text": "The re - irradiation brachytherapy dose ranged from 17.5 to 35 Gy in single doses of 2.5 Gy ( 2 Gy in one patient ) twice daily .", "label": "", "metadata": {}, "score": "50.319077"}
{"text": "Patients Characteristics at Relapse .Median time to late relapse was 7 years ; very late relapses occurred 5 to 18 years after treatment start ( Table 2 ) .", "label": "", "metadata": {}, "score": "50.424515"}
{"text": "There are limited data relating the use of AHSCT in children compared with adults .Inacase - matchedcomparisonof81pediatricand81 adult patients who underwent AHSCT for relapsed or re- fractory HD , Williams et al29found similar PFS and OS rates as well as similar procedure - related toxicities and mortality between the two age groups .", "label": "", "metadata": {}, "score": "50.824593"}
{"text": "Another report [ 20 ] of patients in early stage HL revealed 4.6 % of very late relapse ( more than 4 years ) .These investigators found that these patients had better survival than did patients with early relapse .", "label": "", "metadata": {}, "score": "50.982056"}
{"text": "122 - 125 , 1992 .View at Google Scholar \u00b7 View at Scopus .T. S. Herman , R. T. Hoppe , S. S. Donaldson , R. S. Cox , S. A. Rosenberg , and H. S. Kaplan , \" Late relapse among patients treated for Hodgkin 's disease , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "51.102448"}
{"text": "5 , pp .435 - 437 , 1992 .View at Google Scholar \u00b7 View at Scopus . A. P. Anselmo , C. Cartoni , E. Panzini , R. M. Enrici , C. Biagini , and F. Mandelli , \" Recurrence of Hodgkin 's disease after 10 years : observation of 5 cases , \" Acta Haematologica , vol .", "label": "", "metadata": {}, "score": "51.111626"}
{"text": "Salvage treatment induced complete remission in 14 pts ( 87.5 % ) .The probability of failure - free survival at 5 years was 75 % .", "label": "", "metadata": {}, "score": "51.342247"}
{"text": "A Gammamed 12i HDR remote afterloader with an iridium-192 source was used .Results : The sites of cancer recurrence were the floor of the mouth and the tongue in 15 patients and the base of the tongue in 5 patients .", "label": "", "metadata": {}, "score": "51.50399"}
{"text": "These would have eventually manifested as nodal recurrence when the nodal drainage areas were left untreated .The second and probably most important difference was that the entire neck of patients in former studies was not irradiated , whereas only the lower neck in our UNI arm was omitted from the prophylactic irradiation protocol .", "label": "", "metadata": {}, "score": "51.536034"}
{"text": "[20 ] found age and B symptoms as predictors for late relapse in early stage patients .The fact that in our study , 14 patients ( 87 % ) had stage I or II disease at the time of very late relapse could be due to the continuous followup of patients in complete remission .", "label": "", "metadata": {}, "score": "51.717484"}
{"text": "After 3DCRT 4/24 ( 16.6 % ) in - field recurrences occurred in regions covered with only 30 - 43 Gy .In the case of 3DCRT mixed beams of photons and electrons were used to optimize dose coverage .", "label": "", "metadata": {}, "score": "51.722893"}
{"text": "One patient devel- oped acute lymphoblastic leukemia 10 months after trans- plantation and is alive 94 months later without evidence of HD recurrence .Prognostic Implications Cox regression analysis consistently identified two of thesevenfactorsaspredictorsofpooroutcomesforeachof the three end points of OS , EFS , and PFS ( P ?", "label": "", "metadata": {}, "score": "51.776833"}
{"text": "Over the past 30 years , the prognosis of localised osteosarcoma has significantly improved .At initial diagnosis , age , axial localisation , metastatic status , and tumour size have been identified as prognostic factors in addition to histological response and surgical margins [ 21 , 22 ] .", "label": "", "metadata": {}, "score": "51.79984"}
{"text": "Indeed , patients in poor clinical condition , with rapidly progressing disease and unresectable disease , were probably not offered this therapy .Thus , the patients who did receive the therapy probably had a better prognosis than the entire cohort of patients with recurrent osteosarcoma .", "label": "", "metadata": {}, "score": "51.83866"}
{"text": "The re - irradiation of relapse occurred 6 months to 5 years after primary therapy .Primary therapy consisted in 11/20 patients in surgical resection and adjuvant radiotherapy , in 9/20 patients a definitive radio chemotherapy was carried out previously .", "label": "", "metadata": {}, "score": "51.91272"}
{"text": "However , approximately 30 to 40 % of patients will relapse , mostly within the first 3 years from diagnosis , and their prognosis is poor , with 5-year OS between 20 and 28 % [ 3 ] .", "label": "", "metadata": {}, "score": "51.983612"}
{"text": "Patients with relapsed HL should be identified according to their prognostic factors at relapse ( duration of remission and extranodal disease or stage ) .This enables relapsing patients to be separated in to three different prognostic groups ; primary refractory patients should be included in the unfavourable group because of their poor prognosis .", "label": "", "metadata": {}, "score": "52.060307"}
{"text": "Participants were followed for a year .The data was analyzed by student - t and chi - square tests , logistic , and Cox regression analysis , and Kaplan - Meier curves in SPSS(19 ) .", "label": "", "metadata": {}, "score": "52.073475"}
{"text": "560 - 568 , 2012 .View at Publisher \u00b7 View at Google Scholar . D. O'Mahony , J. E. Janik , J. A. Carrasquillo , et al . , \" Yttrium-90 radiolabeled humanized monoclonal antibody to CD25 in refractory and relapsed Hodgkin 's lymphoma , \" Blood , vol .", "label": "", "metadata": {}, "score": "52.208187"}
{"text": "Treatment of relapse consisted of chemotherapy alone in 13 pts ( 81 % ) and chemotherapy and radiotherapy in 3 ( 19 % ) .Among 6 patients initially treated with MOPP / ABVD , 4 were retreated with MOPP / ABVD and 2 received ABVD .", "label": "", "metadata": {}, "score": "52.379597"}
{"text": "Miniero and colleagues reported the feasibility of combining high dose carboplatin and etoposide in a series of 6 patients with relapsed osteosarcomas , but the study size was too small to demonstrate a benefit in terms of survival [ 25 ] .", "label": "", "metadata": {}, "score": "52.38025"}
{"text": "A report from the International Bone Marrow Transplant Registry of 114 patients with lymphoma undergoing myeloablative allogeneic transplants reported a rate of disease progression at 3 years of 52 % and TRM of 22 % .", "label": "", "metadata": {}, "score": "52.516354"}
{"text": "They received a total of 37 courses of IDA - FLAG and/or FLAG ( IDA - FLAG without idarubicin ) .Overall , nine patients remain in continuous complete remission with a median duration of 17.5 months ( 9.5 - 39 months ) .", "label": "", "metadata": {}, "score": "52.561954"}
{"text": "[ 27 ] , in an analysis of all stages , reported that very late relapses were more frequent in patients with more extensive disease at diagnosis , nonnodular sclerosing histology , who had been treated with chemotherapy only ( versus combined modality ) .", "label": "", "metadata": {}, "score": "52.578026"}
{"text": "Information regarding the role of allogeneic SCT for HL in the pediatric population is very limited . \" Long - term survival of only 20 % was reported for patients who failed this option .", "label": "", "metadata": {}, "score": "52.697952"}
{"text": "21 , no .4 , pp .607 - 614 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. R. Dom\u00ednguez , A. M\u00e1rquez , J. Gum\u00e1 et al . , \" Treatment of stage I and II Hodgkin 's lymphoma with ABVD chemotherapy : results after 7 years of a prospective study , \" Annals of Oncology , vol .", "label": "", "metadata": {}, "score": "52.73694"}
{"text": "Chan AT , Leung SF , Ngan RK , et al .Overall survival after concurrent cisplatin - radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma .", "label": "", "metadata": {}, "score": "52.740837"}
{"text": "Since the clinical features that correlate with relapse are also associated with a decreased likelihood of achieving an initial remission , these patients should be offered participation in clinical trials of dose - intensive treatment strategies aimed at improving the rates and durability of complete responses .", "label": "", "metadata": {}, "score": "52.98221"}
{"text": "Differences in survival estimates between groups were assessed by Log - Rank test [ 18 ] .Median follow - up was calculated using reverse Kaplan - Meier estimation .", "label": "", "metadata": {}, "score": "53.00434"}
{"text": "Duration of remission and survival following reinduction therapy with the IDA - FLAG / FLAG regimen are shown in Table IV .For 11/17 responders the duration of the second CR was longer than the duration of first CR with a median duration of 13\u00b75 months and 10 months , respectively .", "label": "", "metadata": {}, "score": "53.04065"}
{"text": "7/23 patients received other relapse chemotherapies prior to IDA - FLAG or FLAG regimen .The cumulative equivalent doses of anthracyclines prior to the IDA - FLAG regimen were 100 - 680mg / m2(median 400mg / m2 ) with no clinical and echocardiographic evi- dence of cardiomyopathy .", "label": "", "metadata": {}, "score": "53.041004"}
{"text": "The patient exhibited prolonged febrile neutropenia for more than one month during the initial course of chemotherapy , but exhibited rapid relapse again , soon following neutropenia recovery .", "label": "", "metadata": {}, "score": "53.060318"}
{"text": "817 - 820 , 1994 .View at Google Scholar \u00b7 View at Scopus . H. Venkatesh , N. Di Bella , T. P. Flynn , M. J. Vellek , K. A. Boehm , and L. Asmar , \" Results of a phase II multicenter trial of single - agent gemcitabine in patients with relapsed or chemotherapy - refractory Hodgkin 's lymphoma , \" Clinical Lymphoma , vol .", "label": "", "metadata": {}, "score": "53.074123"}
{"text": "814 - 822 , 1997 .View at Google Scholar \u00b7 View at Scopus . D. Zamir , I. Leibovitz , I. Polyschuck , T. Reitblat , and G. Lugassy , \" Very late relapse of Hodgkin 's lymphoma , \" Israel Medical Association Journal , vol .", "label": "", "metadata": {}, "score": "53.131004"}
{"text": "59 - 63 , 2000 .View at Google Scholar \u00b7 View at Scopus . H. Bohlen , M. Kessler , M. Sextro , V. Diehl , and H. Tesch , \" Poor clinical outcome of patients with Hodgkin 's disease and elevated interleukin-18 serum levels .", "label": "", "metadata": {}, "score": "53.164726"}
{"text": "The authors suggested that the similarity in survival reflected the fact that close to 50 % of the pa- tients who relapsed after Dexa - BEAM ultimately received AHSCT .", "label": "", "metadata": {}, "score": "53.26604"}
{"text": "The small number of observations in our study did not allow analysis of different AHSCT regimens as an additional covariate .DISCUSSION CurrentmethodsoftreatmentforpediatricHDyield5-year EFS rates of 80 % to 90%.42 - 46Unfortunately , the prognosis remainspoorforpatientswithprimaryrefractorydiseaseor Table 3 . 3.4 1.0 1.6 2.5 3.4 1.5 5.1 1.1 to 10.6 0.9 to 1.0 0.5 to 4.6 0.9 to 7.1 0.9 to 12.0 0.5 to 4.3 1.6 to 16.9 .30 .17 .91 .04 ? 1.6 1.0 1.1 2.7 3.0 1.4 3.8 0.6 to 4.1 0.9 to 1.0 0.4 to 3.0 0.1 to 6.7 1.0 to 9.1 0.5 to 3.8 1.2 to 12.0 .73 .35 .93", "label": "", "metadata": {}, "score": "53.29528"}
{"text": "3483 - 3489 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Josting , U. Rueffer , J. Franklin , M. Sieber , V. Diehl , and A. Engert , \" Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma : a report from the German Hodgkin Lymphoma Study Group , \" Blood , vol .", "label": "", "metadata": {}, "score": "53.295326"}
{"text": "[ 22 ] reported that very late relapses in early stage patients were more frequent in males with B symptoms at diagnosis and mediastinal involvement , who had been treated with radiotherapy only ( versus combined modality ) .", "label": "", "metadata": {}, "score": "53.418316"}
{"text": "4 , pp .284 - 286 , 1995 .View at Google Scholar \u00b7 View at Scopus .B. D. Cheson , S. J. Horning , B. Coiffier et al . , \" Report of an international workshop to standardize response criteria for non - Hodgkin 's lymphomas , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "53.430977"}
{"text": "Patients refractory to first - line treatment , as well as early relapsed patients and patients with a secondary AML , are poor responders to classic salvage reinduction therapy ( Kantarjian et al , 1993 ; Stahnke et al , 1992 ) .", "label": "", "metadata": {}, "score": "53.442955"}
{"text": "Sun JD , Chen CZ , Chen JZ , et al .Long term outcomes and prognostic factors of N0 stage nasopharyngeal carcinoma : a single institutional experience with 610 patients .", "label": "", "metadata": {}, "score": "53.481285"}
{"text": "Overall , 75 % of patients with stage III disease can be expected to survive 5 years .International Prognostic Index Scoring for intermediate to high grade lymphoma Received 12 November 2013 ; Accepted 15 December 2013 ; Published 4 February 2014 .", "label": "", "metadata": {}, "score": "53.49254"}
{"text": "259 - 262 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Younes , A. Sureda , D. Ben - Yehuda , et al . , \" Panobinostat in patients with relapsed / refractory Hodgkin 's lymphoma after autologous stem - cell transplantation : results of a Phase II Study , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "53.500443"}
{"text": "Results : The sites of cancer recurrence were the floor of the mouth and the tongue in 15 patients and the base of the tongue in 5 patients .", "label": "", "metadata": {}, "score": "53.501255"}
{"text": "Our review of AHSCT for pediatric patients with re- lapsed or refractory HD demonstrates 5-year OS , EFS , and PFSratescomparabletothoseachievedatothercentersand superior to results obtained by retrieval chemotherapy alone .", "label": "", "metadata": {}, "score": "53.58735"}
{"text": "GO was administered alone , at a unit dose of 3 - 9 mg / m2 , once ( 3 patients ) , twice ( 3 patients ) , three ( 5 patients ) or five times ( 1 patient ) .", "label": "", "metadata": {}, "score": "53.690376"}
{"text": "Methods : From November 2001 to December 2004 20 patients in the age of 36 to 95 years ( median 60 years ) with locally relapsed head and neck tumors were treated with interstitial HDR brachytherapy in a previous irradiated area in curative intention .", "label": "", "metadata": {}, "score": "53.773598"}
{"text": "748 - 755 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Ferrari , A. Briccoli , M. Mercuri et al . , \" Postrelapse survival in osteosarcoma of the extremities : prognostic factors for long - term survival , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "53.773636"}
{"text": "AllfactorswithaP ? .10inunivariateanalysisweresubjecttostepwiseCoxregressionanalysis .RESULTS Survival Data OS at 5 years was 68 % ( 95 % CI , 52 % to 84 % ; Fig 1 ) .", "label": "", "metadata": {}, "score": "53.775066"}
{"text": "Benefits .60 % relapse - free rates at 10 years ( 70 % for stage IA vs 30 % for stage IIA ) .Extended field irradiation .", "label": "", "metadata": {}, "score": "53.795692"}
{"text": "Surgery was recommended whenever possible , 30 days after the course of chemotherapy .Response Evaluation .A computed tomographic ( CT ) scan was performed between 28 and 60 days following the first intensive thiotepa administration .", "label": "", "metadata": {}, "score": "53.953213"}
{"text": "767 - 773 , 1993 .View at Google Scholar \u00b7 View at Scopus . A. R. Yuen , S. A. Rosenberg , R. T. Hoppe , J. D. Halpern , and S. J. Horning , \" Comparison between conventional salvage therapy and high - dose therapy with autografting for recurrent or refractory Hodgkin 's disease , \" Blood , vol .", "label": "", "metadata": {}, "score": "53.9539"}
{"text": "110 - 113 , 2000 .View at Google Scholar \u00b7 View at Scopus .T. P. Vassilakopoulos , G. Nadali , M. K. Angelopoulou et al . , \" Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin 's lymphoma , \" Haematologica , vol .", "label": "", "metadata": {}, "score": "53.969643"}
{"text": "75 , pp .1084 - 1093 , 1995 .View at Google Scholar .P. M. Anderson , P. Meyers , E. Kleinerman , et al . , \" Mifamurtide in metastatic and recurrent osteosarcoma : a patient access study with pharmacokinetic , pharmacodynamic , and safety assessments , \" Pediatr Blood Cancer , vol .", "label": "", "metadata": {}, "score": "54.026424"}
{"text": "122 - 126 , 1989 .View at Google Scholar \u00b7 View at Scopus .B. Kempf - Bielack , S. S. Bielack , H. J\u00fcrgens et al . , \" Osteosarcoma relapse after combined modality therapy : an analysis of unselected patients in the Cooperative Osteosarcoma Study Group ( COSS ) , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "54.17059"}
{"text": "Yuen AR , Rosenberg SA , Hoppe RT , et al : Comparison between conventional salvage ther- apy and high - dose therapy with autografting for recurrent or refractory Hodgkin 's disease .", "label": "", "metadata": {}, "score": "54.266876"}
{"text": "559 - 568 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M.-D. Tabone , C. Kalifa , C. Rodary , M. Raquin , D. Valteau - Couanet , and J. Lemerle , \" Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "54.317482"}
{"text": "[ 13 , 14 ] More recent studies , including one prospective phase 2 study based on CT or MRI , show that the relapse rate in the neck after upper neck irradiation alone is acceptably low , and recurrence outside the irradiated lower neck is extremely rare .", "label": "", "metadata": {}, "score": "54.428192"}
{"text": "Benefits : a single - institution experience reported a 96 % complete response and 90 % freedom - from- treatment failure at a median follow - up of 4 years .", "label": "", "metadata": {}, "score": "54.458767"}
{"text": "The histologies of the 16 patients in very late relapses were mixed cellularity in 7 ( 44 % ) and nodular sclerosis in 9 ( 56 % ) .", "label": "", "metadata": {}, "score": "54.557846"}
{"text": "Gianni AM , Siena S , Bregni M , et al : High- dose sequential chemo - radiotherapy with periph- eral blood progenitor cell support for relapsed or refractory Hodgkin 's disease : A 6-year update .", "label": "", "metadata": {}, "score": "54.563354"}
{"text": "31 - 36 , 1981 .View at Google Scholar \u00b7 View at Scopus .T. P. Vassilakopoulos , M. K. Angelopoulou , M. P. Siakantaris , et al . , \" Very late relapses in patients with Hodgkins lymphoma , \" Haematologica , vol .", "label": "", "metadata": {}, "score": "54.58888"}
{"text": "Results At a median follow - up of 4.2 years ( range , 0.7 to 11.9 years ) , the 5-year OS , EFS , and PFS rates were 68 % , 53 % , and 63 % , respectively .", "label": "", "metadata": {}, "score": "54.6408"}
{"text": "could be caused by more advanced tumor stages ( 40 T3 , 8 T4 , 26 N2 ) , more aggressive subtypes ( 14 biphasic , 4 sarcomatoid ) and the fact that neoadjuvant chemotherapy was not routinely administered .", "label": "", "metadata": {}, "score": "54.69091"}
{"text": "Between November 2005 and June 2012 , 301 patients with node - negative NPC were randomly assigned to receive primary plus prophylactic upper neck irradiation ( UNI , 153 patients ) or primary plus whole - neck irradiation ( WNI , 148 patients ) .", "label": "", "metadata": {}, "score": "54.88465"}
{"text": "In addition , one patient died from thromboembolic disease , and one died from HCV reactivation without evidence of HL ( Table 2 ) .Of the two patients in PR , one achieved a CR with the IEV regimen and is still in CR after 14 months of followup while the other one died of HL progression .", "label": "", "metadata": {}, "score": "54.947937"}
{"text": "203 - 210 , 2011 .View at Google Scholar . A. Josting , L. Nogov\u00e1 , J. Franklin et al . , \" Salvage radiotherapy in patients with relapsed and refractory Hodgkin 's lymphoma : a retrospective analysis from the German Hodgkin Lymphoma Study Group , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "55.05829"}
{"text": "Blood 77:2322 - 2325 , 1991 28 .Bierman PJ , Bagin RG , Jagannath S , et al : High dose chemotherapy followed by autolo- gous hematopoietic rescue in Hodgkin 's dis- ease : Long - term follow - up in 128 patients .", "label": "", "metadata": {}, "score": "55.058853"}
{"text": "Discussion .The majority of patients with HL can be cured with conventional chemotherapy ( ABVD ) , radiotherapy , or both .Even though HL is curable , approximately 30 % of all patients relapse and eventually die of disease progression or complications of therapy .", "label": "", "metadata": {}, "score": "55.112865"}
{"text": "The patients with clinical stage T1-T3 , N0 - 2 , M0 , R0 - 2 were treated with 3 cycles of preoperative chemotherapy ( pemetrexed and cisplatin ) followed by EPP and RT [ 7 ] .", "label": "", "metadata": {}, "score": "55.117516"}
{"text": "Increasing chemotherapy dose induced short - lasting remission but did not increase survival .High dose chemotherapy with carboplatin , etoposide , ifosfamide , and high dose cyclophosphamide yielded only 28 % response [ 23 ] .", "label": "", "metadata": {}, "score": "55.195343"}
{"text": "Those patients underwent outpatient therapy and did not require intensive hospitalization or autologous stem cell support .Nevertheless , those authors did not clearly describe their inclusion criteria , and we can not compare characteristics between their patients and ours .", "label": "", "metadata": {}, "score": "55.241306"}
{"text": "The main endpoint of the study was to compare the lower neck control rate between the 2 groups .RESULTS .With a median follow - up period of 39 months ( range , 6 - 84 months ) , no patient in either group had a cervical node relapse .", "label": "", "metadata": {}, "score": "55.255554"}
{"text": "After transplantation , two patients showed a relapse 2\u00b75 months and 6 months following the autologous or allogeneic BMT .There was no treatment failure caused by early death .", "label": "", "metadata": {}, "score": "55.362762"}
{"text": "Factors associated with poor outcome ( P ? .10 ) , which were then included in multivariate analysis .Lieskovsky et al 4536 JOURNAL OF CLINICAL ONCOLOGY Downloaded from jco.ascopubs.org on October 21 , 2015 .", "label": "", "metadata": {}, "score": "55.383656"}
{"text": "Pretreatment factors were analyzed by univariate and multivariate analysis for prognostic significance for 5-year overall survival ( OS ) , event - free survival ( EFS ) , and progression - free survival ( PFS ) .", "label": "", "metadata": {}, "score": "55.421364"}
{"text": "View at Google Scholar .M. A. Dimopoulos , E. Kostis , A. Anagnostopoulos , M. Dalezios , C. Papadimitris , and C. Papadimitriou , \" Very late relapse of Hodgkin 's disease after 24 years of complete remission , \" Leukemia and Lymphoma , vol .", "label": "", "metadata": {}, "score": "55.42428"}
{"text": "Chen JZ , Le QT , Han F , et al .Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and Vb in patients with N(0 - 1 ) nasopharyngeal carcinoma .", "label": "", "metadata": {}, "score": "55.428543"}
{"text": "Between 1999 and 2011 , 39 patients were treated with neoadjuvant chemotherapy and EPP followed by RT .All follow up patients were deceased at the time of this study .", "label": "", "metadata": {}, "score": "55.520382"}
{"text": "[ 3 ] Therefore , it has long been accepted that the bilateral cervical regions should be electively irradiated for potentially metastatic nodes .[ 4 , 5 ] Currently , most clinical protocols , such as RTOG-0225 ( Radiation Therapy Oncology Group-0225 ) , recommend the routine elective irradiation of node groups II to V and the supraclavicular nodal areas , regardless of the nodal status .", "label": "", "metadata": {}, "score": "55.6025"}
{"text": "L by day 14 and a platelet count of more than 20 ?L by day 13 , but he experienced a subsequent drop in his blood counts , with ANC decreasing to 0 on day 35 and platelets decreasing to 6 ?", "label": "", "metadata": {}, "score": "55.673527"}
{"text": "112 - 113 , 2004 .View at Google Scholar \u00b7 View at Scopus .J. D. Brierley , A. J. Rathmell , M. K. Gospodarowicz , S. B. Sutcliffe , and M. Pintillie , \" Late relapse after treatment for clinical Stage I and II Hodgkin 's disease , \" Cancer , vol . 79 , no . 7 , pp .", "label": "", "metadata": {}, "score": "55.67577"}
{"text": "An interval of 5 years was chosen because the actuarial rate of relapse appeared to reach a plateau at 5 years [ 17 - 27 ] .", "label": "", "metadata": {}, "score": "55.700047"}
{"text": "776 - 790 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D.Andreou , S. S. Bielack , D. Carrle et al . , \" The influence of tumor- and treatment - related factors on the development of local recurrence in osteosarcoma after adequate surgery .", "label": "", "metadata": {}, "score": "56.04801"}
{"text": "Moreover , most of these reports are based on small numbers of patients and heterogeneous therapeutic modalities [ 7 , 12 - 14 ] .Its efficacy against osteosarcomas has been suggested in a previous study of the French Society of Paediatric Oncology ( Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer de l'Enfant ; SFCE ) [ 16 ] but remains to be demonstrated in a larger number of patients .", "label": "", "metadata": {}, "score": "56.10799"}
{"text": "116 - 123 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .B. Sirohi , D. Cunningham , R. Powles et al . , \" Long - term outcome of autologous stem - cell transplantation in relapsed or refractory Hodgkin 's lymphoma , \" Annals of Oncology , vol .", "label": "", "metadata": {}, "score": "56.11139"}
{"text": "A pathologist centrally reviewed histological reports of all patients who underwent surgery and assessed and classified histological responses into 2 groups .Good histological response was defined as no residual tumour , predominant fibrosis , and osteoid matrix with no or exceptional visible viable cells .", "label": "", "metadata": {}, "score": "56.1544"}
{"text": "292 - 297 , 1985 .View at Google Scholar \u00b7 View at Scopus .J. R. Kanofsky , H. M. Golomb , J. E. Vardiman , D. L. Sweet , and J. E. Ultmann , \" Late relapses in Hodgkin disease , \" American Journal of Hematology , vol .", "label": "", "metadata": {}, "score": "56.221878"}
{"text": "257 - 264 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. P. Robinson , A. Sureda , C. Canals et al . , \" Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin 's lymphoma : identification of prognostic factors predicting outcome , \" Haematologica , vol .", "label": "", "metadata": {}, "score": "56.270287"}
{"text": "All four of the patients had received irradiation as a part of their pri- mary combined - modality treatment .Only one of the four patientsrelapsedinasitethathadbeeninvolvedatthetime of transplantation .", "label": "", "metadata": {}, "score": "56.44675"}
{"text": "4 , pp .1280 - 1286 , 2000 .View at Google Scholar \u00b7 View at Scopus .C. Ferm\u00e9 , Y. Bastion , P. Brice et al . , \" Prognosis of patients with advanced Hodgkin 's disease : evaluation of four prognostic models using 344 patients included in the group d'etudes des lymphomes de l'adulte study , \" Cancer , vol .", "label": "", "metadata": {}, "score": "56.471863"}
{"text": "Better local control after HCRT did not translate into improved overall survival in our patient series .Remarkably , the rate of death due to intercurrent disease , most often cardiac events , was higher after HCRT ( 29 % ) in comparison to 3DCRT ( 4 % ) .", "label": "", "metadata": {}, "score": "56.52235"}
{"text": "Huvos grading [ 20 ] is not applicable , and we decided to classify patients as good responders only if they had no residual tumour , predominant fibrosis , and osteoid matrix with no or exceptional visible viable cells .", "label": "", "metadata": {}, "score": "56.5698"}
{"text": "Lee AWM , Poon YF , Foo W , et al .Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976 - 1985 : overall survival and patterns of failure .", "label": "", "metadata": {}, "score": "56.572487"}
{"text": "All survival endpoints as well as tumor recurrence were measured from the date of treatment start ( neoadjuvant chemotherapy ) and were evaluated using the Kaplan Meier Method .", "label": "", "metadata": {}, "score": "56.599804"}
{"text": "Most studies focused on early relapses should lead to improved first - line treatment approaches and high survival rates .Much less is known about very late relapse in terms of incidence and outcome [ 17 - 31 ] .", "label": "", "metadata": {}, "score": "56.610905"}
{"text": "With the routine use of modern imaging in the staging of NPC , the exact volumes that need to be irradiated to obtain the optimal outcomes became controversial , especially for patients with node - negative disease .", "label": "", "metadata": {}, "score": "56.647293"}
{"text": "Lee N , Harris J , Garden AS , et al .Intensity - modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma : Radiation Therapy Oncology Group phase II trial 0225 .", "label": "", "metadata": {}, "score": "56.690193"}
{"text": "Although there are many treatment strategies , the standard approach is still lacking .Crump [ 9 ] devised a treatment approach for such patients which seems to be optimal .", "label": "", "metadata": {}, "score": "56.69729"}
{"text": "Myeloablative strategies were reported to be able to achieve cure in some younger patients , but high nonrelapse mortality remains a problem .Reduced intensity conditioning , in turn , was found to be associated with high posttransplant relapse rates .", "label": "", "metadata": {}, "score": "56.749214"}
{"text": "Haematological toxicity After exclusion of nonresponders and of the patient who died due to therapy - related courses , 20/24 IDA - FLAG courses and 11/13 FLAG courses were evaluable for haematological toxicity .", "label": "", "metadata": {}, "score": "56.768623"}
{"text": "Several clinical and laboratory features have been used to predict progression - free survival ( PFS ) and overall survival ( OS ) , in order to adjust therapy according to the risk of relapse .", "label": "", "metadata": {}, "score": "56.807373"}
{"text": "The institutional review board ap- proved all clinical research protocols .Definitions Relapsed disease was defined as histologically proven disease recurrence ?60 days after successful primary treatment .", "label": "", "metadata": {}, "score": "56.84256"}
{"text": "Weiner MA , Leventhal BG , Marcus R , et al : Intensive chemotherapy and low - dose radio- therapy for the treatment of advanced - stage Hodgkin 's disease in pediatric patients : A Pedi- atric Oncology Group study .", "label": "", "metadata": {}, "score": "56.919876"}
{"text": "432 - 439 , 1983 .View at Google Scholar \u00b7 View at Scopus .P. J. Bierman , R. G. Bagin , S. Jagannath et al . , \" High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin 's disease : long term follow - up in 128 patients , \" Annals of Oncology , vol .", "label": "", "metadata": {}, "score": "56.954163"}
{"text": "4 , pp .710 - 715 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. F. Huth and F. R. Eilber , \" Patterns of recurrence after resection of osteosarcoma of the extremity . strategies for treatment of metastases , \" Archives of Surgery , vol .", "label": "", "metadata": {}, "score": "56.994637"}
{"text": "L and there was no dose - limiting toxicity .Tumor Response Evaluation Restaging studies ( CBC , complete metabolic panel , chest x - ray , and computed tomography scans ) were obtained between day ? 30 and day ? 60 after transplantation .", "label": "", "metadata": {}, "score": "57.051914"}
{"text": "230 - 238 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .B. Sarina , L. Castagna , L. Farina et al . , \" Allogeneic transplantation improves the overall and progression - free survival of Hodgkin lymphoma patients relapsing after autologous transplantation : a retrospective study based on the time of HLA typing and donor availability , \" Blood , vol .", "label": "", "metadata": {}, "score": "57.06683"}
{"text": "Multivariate analysis determined the following three factors to be significant predictors of poor OS and EFS : extranodal disease at first relapse , presence of mediastinal mass at time of AHSCT , and primary induction failure .", "label": "", "metadata": {}, "score": "57.20975"}
{"text": "The median follow - up period was 39 months ( range , 6 - 84 months ) .There was no confirmed case of cervical node relapse including the lower neck relapse in either of the 2 groups .", "label": "", "metadata": {}, "score": "57.28077"}
{"text": "101 , no . 1 , pp .14 - 18 , 1977 .View at Google Scholar \u00b7 View at Scopus . S. S. Bielack , B. Kempf - Bielack , G. Delling et al . , \" Prognostic factors in high - grade osteosarcoma of the extremities or trunk : an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "57.282482"}
{"text": "23 , pp .4934 - 4937 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. Derenzini , D. Buglio , and A. Younes , \" Novel therapy of relapsed and refractory classical Hodgkin 's lymphoma , \" European Oncology & Haematology , vol .", "label": "", "metadata": {}, "score": "57.306168"}
{"text": "5 , pp .1473- 1483 , 1996 .View at Google Scholar \u00b7 View at Scopus . U.M. Saarinen , L. Hovi , A. Makipernaa , and P. Riikonen , \" High - dose thiotepa with autologous bone marrow rescue in pediatric solid tumors , \" Bone Marrow Transplantation , vol . 8 , no .", "label": "", "metadata": {}, "score": "57.319374"}
{"text": "457 - 481 , 1958 .View at Google Scholar .R. Peto , C. Pike , and P. Armitage , \" Design and analysis of randomized clinical trials requiring prolonged observation of each patient .", "label": "", "metadata": {}, "score": "57.401604"}
{"text": "Statistical Analysis .The primary endpoint of the study was to compare the lower neck control rate of node - negative NPC treated with primary and upper neck irradiation versus primary and whole - neck irradiation .", "label": "", "metadata": {}, "score": "57.457253"}
{"text": "Before AHSCT , patients were required to demonstrate adequate hematologic parameters ( WBC ?L and platelets ?L , unless there was biopsy - proven bone marrow involvement ) , pulmonary function ( diffusion capacity ? 60 % ) , cardiac function ( radionuclide ejection fraction ?", "label": "", "metadata": {}, "score": "57.494625"}
{"text": "Josting A , Rudolph C , Reiser M , et al : Time - intensified dexamethasone / cisplatin / cytar- abine : An effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin 's disease .", "label": "", "metadata": {}, "score": "57.502968"}
{"text": "55 - 69 , 1997 .View at Google Scholar \u00b7 View at Scopus .J. P. Perentesis , E. Katsanis , T. E. DeFor , J. P. Neglia , and N. K. C. Ramsay , \" Autologous stem cell transplantation for high - risk pediatric solid tumors , \" Bone Marrow Transplantation , vol .", "label": "", "metadata": {}, "score": "57.54509"}
{"text": "No death related to high dose TTP was documented and no patient experienced life - threatening extrahaematologic severe toxicity .Responses and Survival .Six patients were not evaluable for radiological response because high dose TTP was administered after surgery .", "label": "", "metadata": {}, "score": "57.55"}
{"text": "Full - text .Patients and Methods From 1989 to 2001 , 41 pediatric patients with relapsed or primary refractory HD underwent high - dose therapy followed by AHSCT according to one of four autologous transplantation protocols at Stanford University Medical Center ( Stanford , CA ) .", "label": "", "metadata": {}, "score": "57.569054"}
{"text": "At each follow - up visit , patients would undergo a complete physical examination and nasopharyngoscopy .Local relapse was confirmed by pathological study of any mass on nasopharyngoscopy or imaging studies that showed progressive bone erosion or continuous enlargement of the parapharyngeal mass .", "label": "", "metadata": {}, "score": "57.636086"}
{"text": "Most patients were treated by conventional radiotherapy before 2009 and by IMRT thereafter , which could bring a potential bias into interpreting the results of treatment .", "label": "", "metadata": {}, "score": "57.640984"}
{"text": "[ 27 ] .The investigators observed that patients with LH more often developed very late relapse when they were treated with less intensive therapy .", "label": "", "metadata": {}, "score": "57.755035"}
{"text": "However , the prognosis of patients relapsing or presenting with metastatic disease at diagnosis is very poor , with 3-year OS of 10 to 50 % and relapse - free survival ( RFS ) of 10 to 20 % [ 2 - 7 ] .", "label": "", "metadata": {}, "score": "57.762997"}
{"text": "9323 , pp .2065 - 2071 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. Horning , M. Fanale , S. deVos , et al . , \" Defining a population of Hodgkin lymphoma patients for novel therapeutics : an international effort , \" Annals of Oncology , vol .", "label": "", "metadata": {}, "score": "57.875973"}
{"text": "Both patients who relapsed following MOPP / ABVD plus BEAM + ASCT received escalated BEACOPP .The only patient who relapsed after RT alone received VEPEM - B. Only 1 patient received HDT / ASCT as second - line treatment for very late relapse .", "label": "", "metadata": {}, "score": "57.88806"}
{"text": "Overall 11/23 patients ( 48 % ) were transplanted in CR following the IDA - FLAG / FLAG regimen .Three patients received an autologous ( ABMT :", "label": "", "metadata": {}, "score": "57.917603"}
{"text": "Histologic transformation of low - grade NHL to a more aggressive histology is well recognized , occurring in 30%-70 % of patients during the course of their .", "label": "", "metadata": {}, "score": "57.960842"}
{"text": "In another study , bortezomib was used in combination with gemcitabine in 18 patients with relapsed HL .The overall response rate was 22 % with more treatment related liver toxicity [ 34 ] .", "label": "", "metadata": {}, "score": "58.000916"}
{"text": "The chemotherapy schedules used at diagnosis were : ABVD in 1 ( 6 % ) , MOPP / ABVD in 8 ( 50 % ) , and MOPP in 6 ( 38 % ) .", "label": "", "metadata": {}, "score": "58.006924"}
{"text": "Each cycle of high - dose chemotherapy was started 21 days after the preceding cycle if the absolute neutrophil count ( ANC ) was more than 1,500/ ?", "label": "", "metadata": {}, "score": "58.010086"}
{"text": "3011 - 3016 , 1998 .View at Google Scholar \u00b7 View at Scopus . A. Santoro , V. Bonfante , and G. Bonadonna , \" Salvage chemotherapy with ABVD in MOPP - resistant Hodgkin 's disease , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "58.101746"}
{"text": "In the current study , between January 1994 and July 1997 , 23 patients were entered from eight departments of paediatric haematology / oncology in Germany and Austria .", "label": "", "metadata": {}, "score": "58.1281"}
{"text": "The cumulative TRM rate at 2 years was 7 % in the alemtuzumab cohort and 29 % in the \" FluMel only \" group .Nevertheless , both the 3-year cumulative incidence of relapse ( 54 % versus 44 % ) and 3-year PFS ( 43 % versus 25 % ) were higher in patients with the FluMel / alemtuzumab regimen .", "label": "", "metadata": {}, "score": "58.151928"}
{"text": "Response evaluation and statistical methods .Evaluation of antileukaemicresponse , especially complete remission ( CR ) and partial remission ( PR ) , was based on CALGB criteria ( Yates et al , 1982 ) .", "label": "", "metadata": {}, "score": "58.299637"}
{"text": "Another TRM due to pulmonary thromboembolism was observed in second complete remission , 2 months after the completion of chemotherapy .In conclusion , very late relapse occurs in a small number of patients with HL , which emphasizes the need for continuous followup .", "label": "", "metadata": {}, "score": "58.36532"}
{"text": "80 % tumor reduction in two tumor dimensions in patients who had persistent radiographic abnormalities that remained unchanged for more than 1 year.34 Bulky disease was defined as mediastinal disease of one third or greater of the maximal intrathoracic diameter as measured on an upright posteroanterior chest radiograph .", "label": "", "metadata": {}, "score": "58.463295"}
{"text": "The precise comparison of the different postinduction approaches in our study was impossible because of the limited patient number and the lack of randomization .11 patients were transplanted in second CR and seven of them are now in continuous CR ( CCR ) .", "label": "", "metadata": {}, "score": "58.75327"}
{"text": "Ritter , J. , Creutzig , U. & Schellong , G. ( 1992 )Treatment results of three consecutive German childhood AML trials : BFM-78 , -83 , and -87 .", "label": "", "metadata": {}, "score": "58.81758"}
{"text": "These include radiotherapy , second ASCT , allogeneic stem cell transplant ( Allo - SCT ) , monoclonal antibodies , chemotherapeutic drugs , and novel agents [ 9 , 10 ] .", "label": "", "metadata": {}, "score": "58.82586"}
{"text": "5 , pp .327 - 333 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Viviani , P. Notti , V. Bonfante , P. Verderio , P. Valagussa , and G. Bonadonna , \" Elevated pretreatment serum levels of IL-10 are associated with a poor prognosis in Hodgkin 's disease , the milan cancer institute experience , \" Medical Oncology , vol .", "label": "", "metadata": {}, "score": "58.902695"}
{"text": "Page 9 . with high - dose chemotherapy with autologous haemopoietic stem - cell transplantation for re- lapsed chemosensitive Hodgkin 's disease : A ran- domised trial .", "label": "", "metadata": {}, "score": "58.93743"}
{"text": "Indications and dose of radiotherapy depends on primary therapy and relapse locations .Given that the cumulative incidence of HL relapse is around 10 % , collecting data over a long period is a challenge .", "label": "", "metadata": {}, "score": "58.9438"}
{"text": "139 - 143 , 1982 .View at Google Scholar \u00b7 View at Scopus .N. Tannir , F. Hagemeister , W. Velasquez , and F. Cabanillas , \" Long - term follow - up with ABDIC salvage chemotherapy of MOPP - resistant Hodgkin 's disease , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "58.97377"}
{"text": "4 , pp .337 - 342 , 1995 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Kletzel , G. L. Kearns , T. G. Wells , and H. C. Thompson Jr. , \" Pharmacokinetics of high dose thiotepa in children undergoing autologous bone marrow transplantation , \" Bone Marrow Transplantation , vol .", "label": "", "metadata": {}, "score": "59.05394"}
{"text": "Clinical remission was observed in patients regardless of CD20 expression by HRS cells and was limited in patients whose disease was confined to the lymph nodes [ 22 ] .", "label": "", "metadata": {}, "score": "59.05593"}
{"text": "Outside the context of a clinical trial , low - dose chemotherapy should be considered for most patients with HIV infection and a CD4 lymphocyte count under 200 .", "label": "", "metadata": {}, "score": "59.095337"}
{"text": "Involved - field radiotherapy was performed in 11 ( 69 % ) patients .The median radiation dose was 30 Gy ( range : 20 - 36 ) .", "label": "", "metadata": {}, "score": "59.11886"}
{"text": "6 , pp .1361 - 1369 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. J. Moskowitz , J. Yahalom , T. Kewalramani et al . , \" Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma , \" Blood , vol .", "label": "", "metadata": {}, "score": "59.152176"}
{"text": "Methods .Thirty - nine MPM patients were treated with neoadjuvant chemotherapy , extrapleural pneumonectomy ( EPP ) and adjuvant RT .Twenty - five patients were treated with 3DCRT , and 14 with HCRT ( Intensity modulated radiotherapy or volumetric modulated arc therapy ) .", "label": "", "metadata": {}, "score": "59.152397"}
{"text": "Frankovich J , Donaldson SS , Lee Y , et al : High - dose therapy and autologous hematopoi- etic cell transplantation in children with primary refractory and relapsed Hodgkin 's disease : Atopy predicts idiopathic diffuse lung injury syndromes .", "label": "", "metadata": {}, "score": "59.161148"}
{"text": "110 - 115 , 2004 .View at Google Scholar \u00b7 View at Scopus . A. Spencer , K. Reed , and C. Arthur , \" Pilot study of an outpatient - based approach for advanced lymphoma using vinorelbine , gemcitabine and filgrastim , \" Internal Medicine Journal , vol .", "label": "", "metadata": {}, "score": "59.185276"}
{"text": "584 - 588 , 1998 .View at Google Scholar \u00b7 View at Scopus .L. Devizzi , A. Santoro , V. Bonfante et al . , \" Vinorelbine : an active drug for the management of patients with heavily pretreated Hodgkin 's disease , \" Annals of Oncology , vol .", "label": "", "metadata": {}, "score": "59.1908"}
{"text": "369 - 376 , 1991 .View at Google Scholar \u00b7 View at Scopus .G. Saeter , J. Hoie , A. E. Stenwig , A. K. Johansson , E. Hannisdal , and O. P. Solheim , \" Systemic relapse of patients with osteogenic sarcoma .", "label": "", "metadata": {}, "score": "59.192207"}
{"text": "The neutropenia of the FLAG courses was clearly shorter than for the IDA - FLAG courses and was associated with a lower infection rate .A second IDA - FLAG course given in three patients seemed to be more toxic with a prolonged myelosuppression and led to one toxic death .", "label": "", "metadata": {}, "score": "59.222443"}
{"text": "The first Phase I study in children has established a maximum tolerated dose ( MTD ) of 65 mg / m 2 every 21 days .", "label": "", "metadata": {}, "score": "59.274605"}
{"text": "Tang L , Mao Y , Liu L , et al .The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma : analysis of the spread patterns in lymph nodes by magnetic resonance imaging .", "label": "", "metadata": {}, "score": "59.28558"}
{"text": "Logistic regression analysis did not reveal any significant associations between disease type and responsiveness to treatment .This study indicated higher rates of unresponsiveness to treatment while its mortality rate was comparable with other studies .", "label": "", "metadata": {}, "score": "59.29902"}
{"text": "225 - 232 , 1993 .View at Google Scholar \u00b7 View at Scopus .P. L. Zinzani , P. Mazza , F. Gherlinzoni et al . , \" ' Very late ' relapses in Hodgkin 's disease patients : a rare but real phenomenon , \" Haematologica , vol .", "label": "", "metadata": {}, "score": "59.319565"}
{"text": "Both patients who were treated with only one FLAG course were nonresponders .In regard to morphological classifica- tion CRs were observed in 4/6 patients ( 67 % ) with FAB - type M1/M2 , in 10/13 patients ( 77 % ) with FAB - type M4/M5 , and in one of two patients with the FAB - type M7 .", "label": "", "metadata": {}, "score": "59.32419"}
{"text": "Stage III / IV .Chemotherapy .Younger patients .Median disease - free survival is almost always between 1.5 and 3 years , and median overall survival ranges from 5 to 7 years .", "label": "", "metadata": {}, "score": "59.37919"}
{"text": "Donaldson SS , Hudson MM , Lamborn KR , et al : VAMP and low - dose , involved - field radia- tion for children and adolescents with favorable , early - stage Hodgkin 's disease : Results of a pro- spective clinical trial .", "label": "", "metadata": {}, "score": "59.389057"}
{"text": "14 , article 536 , 1994 .View at Google Scholar \u00b7 View at Scopus .S. Bodis , M. Henry - Amar , J. Bosq et al . , \" Late relapse in early - stage Hodgkin 's disease patients enrolled on European Organization for Research and Treatment of Cancer protocols , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "59.441742"}
{"text": "Complete response ( CR ) was defined as the disappearance of all measurable tumours for more than one month ; partial response ( PR ) corresponded to a reduction greater than 50 % .", "label": "", "metadata": {}, "score": "59.460148"}
{"text": "The OS , RFS , and MFS were calculated with the Kaplan - Meier method , and differences between groups were compared by means of the log - rank test .", "label": "", "metadata": {}, "score": "59.46673"}
{"text": "The OS , RFS , and MFS rates did not significantly differ between groups .The results were comparable to those found in recent studies , despite a relatively higher rate of advanced local disease in our study .", "label": "", "metadata": {}, "score": "59.483765"}
{"text": "Only patients with measurable disease were considered evaluable for response .Measurable disease was defined as the presence of at least one lesion that could be accurately measured in at least one dimension , which corresponded to the longest dimension greater than 20 mm with conventional techniques or greater than 10 mm using spiral CT .", "label": "", "metadata": {}, "score": "59.511726"}
{"text": "Leukemia , 6 , ( Suppl , 2 ) , 59 - 62 .Santana , V.M. , Mirro , J. , Jr , Kearns , C. , Schell , M.J. , Crom , W. & Blakley , R.L. ( 1992 ) 2-Chlorodoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia .", "label": "", "metadata": {}, "score": "59.562443"}
{"text": "The use of HCRT increases the probability of local control as compared to 3DCRT by improving target volume coverage .HCRT did not improve overall survival in this patient series due to the high rate of distant recurrences .", "label": "", "metadata": {}, "score": "59.66832"}
{"text": "There is no accurate means to identify patients at risk of very late relapse , and there is no absolutely safe point at which an individual patient may be considered cured of HL and at no risk of very late relapse [ 17 - 31 ] .", "label": "", "metadata": {}, "score": "59.780994"}
{"text": "12 , pp .3797 - 3803 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Anderlini , R. Saliba , S. Acholonu et al . , \" Fludarabine - melphalan as a preparative regimen for reduced - intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin 's lymphoma : the updated M.D. Anderson Cancer Center experience , \" Haematologica , vol .", "label": "", "metadata": {}, "score": "59.92787"}
{"text": "14 , no .4 , pp .665 - 666 , 1994 .View at Google Scholar \u00b7 View at Scopus .R. Miniero , A. Brach del Prever , E. Vassallo et al . , \" Feasibility of high - dose chemotherapy and autologous peripheral blood stem cell transplantation in children with high grade osteosarcoma , \" Bone Marrow Transplantation , vol .", "label": "", "metadata": {}, "score": "59.950188"}
{"text": "Le Deley , J.-M. Guinebreti\u00e8re , J.-C. Gentet et al . , \" SFOP OS94 : a randomised trial comparing preoperative high - dose methotrexate plus doxorubicin to high - dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients , \" European Journal of Cancer , vol .", "label": "", "metadata": {}, "score": "59.994705"}
{"text": "Follow - Up .Treatment results were assessed by complete physical examination , fiberoptic nasopharyngoscopy , MRI ( or CT if MRI was contraindicated ) scans of the head and neck , chest x - ray , and ultrasound of the liver 3 months after radiotherapy .", "label": "", "metadata": {}, "score": "60.016785"}
{"text": "Harker WG , Kushlan P , Rosenberg SA : Combination chemotherapy for advanced Hodgkin 's disease after failure of MOPP : ABVD and B - CAVe .", "label": "", "metadata": {}, "score": "60.023224"}
{"text": "Thiotepa was administered as a 2-hour intravenous infusion , at a dose of 300 mg / m 2 /d for 3 consecutive days .", "label": "", "metadata": {}, "score": "60.027565"}
{"text": "121 - 125 , 1997 .View at Google Scholar \u00b7 View at Scopus .P. Brousset , D. Schlaifer , F. Meggetto et al . , \" Persistence of the same viral strain in early and late relapses of Epstein - Barr virus - associated Hodgkin 's disease , \" Blood , vol .", "label": "", "metadata": {}, "score": "60.13974"}
{"text": "Benefits .Preliminary studies indicate that approximately 20 % to 40 % of patients will have a long - term disease - free status , but the precise percentage depends on patient selection and the specific treatment used .", "label": "", "metadata": {}, "score": "60.15387"}
{"text": "Andre M , Henry - Amar M , Pico JL , et al : Comparison of high - dose therapy and autolo- gous stem - cell transplantation with conventional therapy for Hodgkin 's disease induction failure : A case - control study - Societe Francaise de Greffe de Moelle .", "label": "", "metadata": {}, "score": "60.203106"}
{"text": "18 , pp .2183 - 2189 , 2012 .View at Publisher \u00b7 View at Google Scholar .R. Chen , J. M. Palmer , S. H. Thomas , et al . , \" Brentuximab vedotin enables successful reduced - intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma , \" Blood , vol .", "label": "", "metadata": {}, "score": "60.208668"}
{"text": "The time to relapse was also predictive for failure in 176 children ( Schellong et al , 2005 ) .\" [ Show abstract ] [ Hide abstract ] ABSTRACT : Despite a high curability rate , some patients with Hodgkin lymphoma ( HL ) fail to respond to , or relapse after , primary conventional treatment .", "label": "", "metadata": {}, "score": "60.232002"}
{"text": "In our study patients treated with HCRT showed a tendency for improved progression free survival and local relapse free survival but did not benefit in terms of overall survival due to the high rates of distant relapses .", "label": "", "metadata": {}, "score": "60.293808"}
{"text": "Prognosis and survival .Indolent lymphomas usually have a long overall survival ( 8 - 12 years ) .Median disease - free survival is almost always between 1.5 and 3 years , and median overall survival ranges from 5 to 7 years .", "label": "", "metadata": {}, "score": "60.29563"}
{"text": "Tumor histology was epithelioid for 6 patients and biphasic for 5 patients in each group .The mean age was 59.6 years and 59.8 years for patient 's in the HCRT and 3DCRT group .", "label": "", "metadata": {}, "score": "60.39317"}
{"text": "1312 - 1319 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. E. Filmont , C. Gisselbrecht , X. Cuenca et al . , \" The impact of pre- and post - transplantation positron emission tomography using 18-fluorodeoxyglucose on poor - prognosis lymphoma patients undergoing autologous stem cell transplantation , \" Cancer , vol .", "label": "", "metadata": {}, "score": "60.481087"}
{"text": "Rodenhuis and colleagues have also shown acceptable toxicity giving 2 or 3 courses of high dose TTP at 5-week intervals [ 34 ] .", "label": "", "metadata": {}, "score": "60.502434"}
{"text": "Lucas et al .demonstrated the clinical efficacy of allogeneic EBV - specific CTLs in EBV - positive RR - HL which had previously failed HDC - ASCT .", "label": "", "metadata": {}, "score": "60.55776"}
{"text": "Finally , despite the fact that these patients previously underwent heavy chemotherapy , high dose thiotepa was well tolerated with no severe toxic event reported .", "label": "", "metadata": {}, "score": "60.679237"}
{"text": "904 - 912 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. O. Freytes , F. R. Loberiza , J. D. Rizzo et al . , \" Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma : a report of the International Bone Marrow Transplant Registry , \" Blood , vol .", "label": "", "metadata": {}, "score": "60.684616"}
{"text": "Ng WT , Lee AW , Kan WK , et al .N - staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma : pattern of nodal involvement by radiological levels .", "label": "", "metadata": {}, "score": "60.713352"}
{"text": "Initial evaluation included a complete medical history and physical examination , blood cell count and serum biochemistry profile , thoracoabdominal computed tomography ( CT ) , and bone marrow biopsy at diagnosis and at relapse .", "label": "", "metadata": {}, "score": "60.746975"}
{"text": "In addition , as the spinal cord is blocked when the tolerance dose of 45 Gy is reached , insufficient dose delivery to parts of the mediastinum has been observed , resulting in underdosage to the tumor bed [ 7 ] .", "label": "", "metadata": {}, "score": "60.815697"}
{"text": "G - CSF was recommended from day 5 after PBSC reinjection until 2 consecutive absolute neutrophil counts at 48 h intervals exceeded 0.5 \u00d7 10 9 /L. Supportive care measures were taken according to each centre 's local procedure .", "label": "", "metadata": {}, "score": "60.93148"}
{"text": "Ann Oncol 13:57 - 66 , 2002 ( suppl 1 ) 66 .Borchmann P , Schnell R , Fuss I , et al : Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma .", "label": "", "metadata": {}, "score": "60.94829"}
{"text": "Statistical Analysis .Overall survival was calculated from the first day of treatment with TTP to the date of death from any cause or to last follow - up for living patients ( censored observation ) .", "label": "", "metadata": {}, "score": "61.00421"}
{"text": "A significant number of patients who relapse after stem cell transplant do so in previously involved sites and may present with disease that could be encompassed in a radiation field .", "label": "", "metadata": {}, "score": "61.036655"}
{"text": "View at Google Scholar . A. Josting , C. Rudolph , M. Mapara et al . , \" Cologne high - dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma : results of a large multicenter study of the German Hodgkin Lymphoma Study Group ( GHSG ) , \" Annals of Oncology , vol .", "label": "", "metadata": {}, "score": "61.063725"}
{"text": "143 - 148 , 1987 .View at Google Scholar \u00b7 View at Scopus .R. D. Hart , M. Perloff , and J. F. Holland , \" One - day VATH ( vinblastine , adriamycin , thiotepa , and halotestin ) therapy for advanced breast cancer refractory to chemotherapy , \" Cancer , vol .", "label": "", "metadata": {}, "score": "61.13743"}
{"text": "Differing provisions from the publisher 's actual policy or licence agreement may be applicable .\" The patient did not finish the consolidation course due to prolonged neutropenia .", "label": "", "metadata": {}, "score": "61.18332"}
{"text": "Definition of disease status was based on clinical and radio- graphic presentation before administration of pretransplantation cytoreductive chemotherapy .Involved - field radiotherapy was ad- ministeredtofourpatientsaspartoftheircytoreductiveregimen .", "label": "", "metadata": {}, "score": "61.245914"}
{"text": "These candidate variables were subsequently included in multivariate analysis for the three end points , respectively .Stepwise Cox proportional hazards model analysis de- termined that extranodal disease at time of first relapse and presence of mediastinal mass at the time of transplantation remainedsignificantpredictorsofallthreeoutcomeparam- eters of poor OS , EFS , and PFS ( P ? .05 ; Table 4 ) .", "label": "", "metadata": {}, "score": "61.272736"}
{"text": "View at Google Scholar . A. J. Moskowitz , P. A. Hamlin , M. A. Perales , et al . , \" Phase II study of bendamustine in relapsed and refractory Hodgkin , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "61.545677"}
{"text": "274 - 281 , 2001 .View at Google Scholar \u00b7 View at Scopus .G. Nadali , L. Tavecchia , E. Zanolin et al . , \" Serum level of the soluble form of the CD30 molecule identifies patients with Hodgkin 's disease at high risk of unfavorable outcome , \" Blood , vol .", "label": "", "metadata": {}, "score": "61.552376"}
{"text": "10.1200/JCO.2008.19.8523 View Article PubMed .Rusch VW , Rosenzweig K , Venkatraman E , Leon L , Raben A , Harrison L , Bains MS , Downey RJ , Ginsberg RJ : A phase II trial of surgical resection and adjuvant high - dose hemithoracic radiation for malignant pleural mesothelioma .", "label": "", "metadata": {}, "score": "61.554893"}
{"text": "Analyses were performed on an intention - to - treat ( ITT ) basis .OS was measured from the date of random assignment to the date of death from any cause .", "label": "", "metadata": {}, "score": "61.576385"}
{"text": "Journal of Clinical Oncology , 12 , 671 - 678 .Klinsche Pa \u00a8diatrie , 208 , 229 - 235 .Leukemia , 10 , 13 - 19 .", "label": "", "metadata": {}, "score": "61.58189"}
{"text": "Tseng A Jr , Jacobs C , Coleman CN , et al : Third - line chemotherapy for resistant Hodgkin 's disease with lomustine , etoposide , and metho- trexate .", "label": "", "metadata": {}, "score": "61.65593"}
{"text": "6 , pp .609 - 615 , 1999 .View at Google Scholar \u00b7 View at Scopus .F. Fagioli , M. Aglietta , A. Tienghi et al . , \" High - dose chemotherapy in the treatment of relapsed osteosarcoma : an Italian Sarcoma Group study , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "61.657528"}
{"text": "MINE : 70 % response rate , 50 % complete remission rate , median survival of 2yrs .ESHAP : 60 % response rate , median survival of 1.8yrs .", "label": "", "metadata": {}, "score": "61.686264"}
{"text": "This difference is probably due to a different definition of the time of relapse ( three , five years , or more ) [ 17 - 31 ] .", "label": "", "metadata": {}, "score": "61.691456"}
{"text": "In general , retreatment with standard agents rarely produces a cure in patients whose lymphomas relapse .Patients who relapse with aggressive lymphoma after 3 years in remission have similar prognoses to de novo lymphoma using curative therapy .", "label": "", "metadata": {}, "score": "61.758076"}
{"text": "Some authors have suggested that the circumstances that impaired the immune system may cause the recurrence [ 35 ] .At least part of the late recurrences of HL might be de novo emerging malignancies in patients at elevated genetic risk for developing HL [ 36 ] .", "label": "", "metadata": {}, "score": "61.894814"}
{"text": "V. Diehl , P. M. Mauch , and N. L. Harris , \" Hodgkin 's disease , \" in Cancer : Principles and Practice of Oncology , V. T. Devita Jr. , S. Hellman , and S. A. Rosenberg , Eds . , vol .", "label": "", "metadata": {}, "score": "61.902164"}
{"text": "There are no data in the pediatric HD literature com- paring conventional retrieval therapy with AHSCT .In the adultliterature , therearetwoprospectiverandomizedtrials comparing AHSCT with conventional chemotherapy for relapsed HD .", "label": "", "metadata": {}, "score": "61.915493"}
{"text": "18 , pp .3671 - 3677 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .K. S. Peggs , A. Sureda , W. Qian et al . , \" Reduced - intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma : impact of alemtuzumab and donor lymphocyte infusions on long - term outcomes , \" British Journal of Haematology , vol .", "label": "", "metadata": {}, "score": "61.93806"}
{"text": "Goldstone AH , Gribben JG , McMillan AK , et al : The sixth report of the EBMT registry of ABMT in lymphomas .Bone Marrow Transplant 4:53 , 1989 63 .", "label": "", "metadata": {}, "score": "61.992233"}
{"text": "Acknowledgments .The authors thank Dr. Dominique Ranchere for performing the centralized anatomopathology review and Dr. Philippe Thiesse for reviewing the radiological data .G. Bacci , A. Briccoli , A. Longhi et al . , \" Treatment and outcome of recurrent osteosarcoma : experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy , \" Acta Oncologica , vol .", "label": "", "metadata": {}, "score": "61.99758"}
{"text": "Chopra R , McMillan AK , Linch DC , et al : The place of high - dose BEAM therapy and auto- logous bone marrow transplantation in poor - risk Hodgkin 's disease : A single - center eight - year study of 155 patients .", "label": "", "metadata": {}, "score": "62.02206"}
{"text": "18 , pp .2197 - 2203 , 2012 .View at Publisher \u00b7 View at Google Scholar .P. B. Johnston , D. J. Inwards , J. P. Colgan et al . , \" A phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma , \" American Journal of Hematology , vol . 85 , no .", "label": "", "metadata": {}, "score": "62.030186"}
{"text": "Xiao W - W , Huang S - M , Han F , et al .Local control , survival , and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy .", "label": "", "metadata": {}, "score": "62.031384"}
{"text": "4 , pp .456 - 460 , 2013 .View at Google Scholar .F. Pajonk , K. Pajonk , and W. H. McBride , \" Apoptosis and radiosensitization of Hodgkin cells by proteasome inhibition , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "62.035103"}
{"text": "2150 - 2156 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Sauerbrey , S. Bielack , B. Kempf - Bielack , A. Zoubek , M. Paulussen , and F. Zintl , \" High - dose chemotherapy ( HDC ) and autologous hematopoietic stem cell transplantation ( ASCT ) as salvage therapy for relapsed osteosarcoma , \" Bone Marrow Transplantation , vol .", "label": "", "metadata": {}, "score": "62.18424"}
{"text": "Conclusions : The management of locoregionally recurrent or second primary tumors in a previously irradiated head and neck volume presents a challenging clinical problem .Only a small subset of patients are candidates for potentially curative surgery .", "label": "", "metadata": {}, "score": "62.261574"}
{"text": "Conclusions : The management of locoregionally recurrent or second primary tumors in a previously irradiated head and neck volume presents a challenging clinical problem .Only a small subset of patients are candidates for potentially curative surgery .", "label": "", "metadata": {}, "score": "62.261574"}
{"text": "Medical Pediatric Oncology , 25 , 271 .Dini , G. , Cornish , J.M. , Gadner , H. , Souillet , G. , Vossen , J.M. , Paolucci , P. , Manfredini , L. , Miano , M. & Niethammer , D. ( 1996 ) Bone marrow transplant indications for childhood leukemias : achieving a consensus .", "label": "", "metadata": {}, "score": "62.27326"}
{"text": "In the Phase II trial conducted by the SFCE group in 1987 , children with refractory or relapsed solid tumours received a single course of TTP 900 mg / m 2 followed by stem cell rescue .", "label": "", "metadata": {}, "score": "62.27885"}
{"text": "Kantarjian , H.M. , Keating , M.J. , Walters , R.S. , McCredie , K.B. & Freireich , E.J. ( 1988 )The characteristics and outcome of patients with late relapse acute myelogenous leukemia .", "label": "", "metadata": {}, "score": "62.363884"}
{"text": "Journal of Pediatric Hematology and Oncology , 17 , 185 - 197 .Kantarjian , H.M. , Estey , E.H. & Keating , M.J. ( 1993 )", "label": "", "metadata": {}, "score": "62.394527"}
{"text": "Table IV .Duration of remission and survival following reinduction therapy with IDA - FLAG/ FLAG regimen .Page 6 .Nonhaematological toxicity Nonhaematological system are shown in Table V. All patients and treatment courses ( including patients with treatment failure and nonresponders ) were evaluated for nonhaematological toxicities .", "label": "", "metadata": {}, "score": "62.45402"}
{"text": "The reinduction / consolidation regimen [ IDA - FLAG]-[FLAG ] was tolerated well and the advised option in the continuation of the trial .The other side - effects were mild and reversible , but no severe neuro- toxicity or haemolytic anaemia were observed as reported in previous studies ( Kornblau et al , 1993 ; Di Raimondo et al , 1993 ) .", "label": "", "metadata": {}, "score": "62.492924"}
{"text": "70 - 80 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Younes , A. K. Gopal , S. E. Smith et al . , \" Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin 's lymphoma , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "62.50023"}
{"text": "Prophylactic or therapeutic CNS therapy was adminis- tered in 12/23 patients in an age - dependent dose .Four patients received an intrathecal monotherapy with cytara- bine and seven patients were treated with an intrathecal triple therapy consisting of cytarabine , methotrexate and prednisolone on day 0 or day 1 of each course .", "label": "", "metadata": {}, "score": "62.508087"}
{"text": "171 - 175 , 1992 .View at Google Scholar \u00b7 View at Scopus . H. M. Lazarus , M. D. Reed , T. R. Spitzer , M. S. Rabaa , and J. L. Blumer , \" High - dose i.v .", "label": "", "metadata": {}, "score": "62.54493"}
{"text": "Despite a high clinical success , relapse in Hodgkin lymphoma occurs in 10 - 30 % of cases and 5 - 10 % patients are nonresponsive to initial chemotherapy .", "label": "", "metadata": {}, "score": "62.606598"}
{"text": "J Clin Oncol 15:528 - 534 , 1997 17 .Brusamolino E , Orlandi E , Canevari A , et al : Results of CAV regimen ( CCNU , melphalan , and VP-16 ) as third - line salvage therapy for Hodgkin 's disease .", "label": "", "metadata": {}, "score": "62.651993"}
{"text": "Blood 85:1381 - 1390 , 1995 21 .Weaver CH , Schwartzberg L , Li W , et al : High - dose chemotherapy and autologous periph- eral blood progenitor cell transplant for the treat- ment of Hodgkin 's disease .", "label": "", "metadata": {}, "score": "62.724266"}
{"text": "11 , pp .760 - 766 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .N. L. Bartlett , D. Niedzwiecki , J. L. Johnson et al . , \" Gemcitabine , vinorelbine , and pegylated liposomal doxorubicin ( GVD ) , a salvage regimen in relapsed Hodgkin 's lymphoma : CALGB 59804 , \" Annals of Oncology , vol .", "label": "", "metadata": {}, "score": "62.803665"}
{"text": "A diagnostic rebiopsy should be considered to confirm relapse or progressive disease if the primary diagnosis was not clear and if the relapse is late ( beyond 3 - 5 years of therapy ) or unusual in pattern and in PET positive lesions whenever feasible .", "label": "", "metadata": {}, "score": "62.899696"}
{"text": "Wilson WH , Jain V , Bryant G , et al : Phase I and II study of high - dose ifosfamide , carbopla- tin , and etoposide with autologous bone marrow rescue in lymphomas and solid tumors .", "label": "", "metadata": {}, "score": "62.982018"}
{"text": "Thus , patients with these characteristics seem to need additional or alternative ther- apy . Asignificantconcerninthispatientpopulationispost-AHSCT idiopathic diffuse lung injury syndrome , of which there was an incidence of 39 % in our study .", "label": "", "metadata": {}, "score": "62.982765"}
{"text": "The radiological response rate reported here ( 31 % objective response , 46 % stable disease ) allows us to conclude that high dose TTP is effective in the treatment of osteosarcoma .", "label": "", "metadata": {}, "score": "63.047104"}
{"text": "1892 - 1901 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. E. Witzig , H. Tang , I. N. M. Micallef et al . , \" Multi - institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib ( R115777 ) in patients with relapsed and refractory lymphomas , \" Blood , vol .", "label": "", "metadata": {}, "score": "63.11888"}
{"text": "Microbiologically documented infections without pulmonary involvement were seen in three patients ( enter- ococcus bacteraemia , candidaemia , parvovirus B19 infec- tion ) ; all of them were treated successfully .", "label": "", "metadata": {}, "score": "63.130684"}
{"text": "There are a few published literatures on the treatment options of patients with RR - HL after autotransplant .This paper summarizes the current available treatment modalities in these patients with emphasis on novel drugs .", "label": "", "metadata": {}, "score": "63.146435"}
{"text": "4 , pp .227 - 233 , 1992 .View at Google Scholar \u00b7 View at Scopus .R. Ladenstein , T. Philip , and H. Gardner , \" Autologous stem cell transplantation for solid tumors in children , \" Current Opinion in Pediatrics , vol .", "label": "", "metadata": {}, "score": "63.17825"}
{"text": "PFS at 5 years was 63 % ( 95 % CI , 46 % to 80 % ; Fig 3 ) .The median follow - up was 4.2 years ( range , 0.7 to 11.9 years ) .", "label": "", "metadata": {}, "score": "63.235416"}
{"text": "Cancer .How to Cite .Li , J.-G. , Yuan , X. , Zhang , L.-L. , Tang , Y.-Q. , Liu , L. , Chen , X.-D. , Gong , X.-C. , Wan , G.-F. , Liao , Y.-L. , Ye , J.-M. and Ao , F. ( 2013 ) , A randomized clinical trial comparing prophylactic upper versus whole - neck irradiation in the treatment of patients with node - negative nasopharyngeal carcinoma .", "label": "", "metadata": {}, "score": "63.275894"}
{"text": "Our data suggest indeed , that the use of HCRT bears considerable potential to improve on hemi - thoracic tumor control rates most likely due to improved target volume coverage .", "label": "", "metadata": {}, "score": "63.327858"}
{"text": "The authors of that study recommended that irradiation of the neck should be withheld until clinical metastases become evident .[ 3 , 21 ] .", "label": "", "metadata": {}, "score": "63.45539"}
{"text": "Improved reinduction rates have reported using high - dose cytarabine ( HD - ARA - C ) in combination with anthracyclines ( Stahnke et al , 1992 ; Hiddemann et al , 1993 ; Wells et al , 1994a ; Archimbaud et al , 1995 ) .", "label": "", "metadata": {}, "score": "63.478657"}
{"text": "Ritter , J. , Creutzig , U. , Gadner , H. , Fink , F.M. & Herrmann , J. ( 1993 )Therapiestudie AML - BFM-93 fu \u00a8r die akute myeloische Leuka \u00a8mie bei Kindern , pp . 1 - 54 .", "label": "", "metadata": {}, "score": "63.549953"}
{"text": "Severe complications of the lung with grade 4 and 5 pneumonitis after IMRT have been reported [ 7 , 12 ] .Since then , special attention to the contralateral lung dose has been given during the treatment planning process and pneumonitis rates should be lower today .", "label": "", "metadata": {}, "score": "63.607136"}
{"text": "The current case report presents a 20-year - old male with acute lymphoblastic leukemia who developed disseminated Fusarium infection during induction chemotherapy .Early diagnosis and treatment is extremely important since the mortality rate is extremely high in such patients .", "label": "", "metadata": {}, "score": "63.62846"}
{"text": "Prior to the 1970s , most patients with stage I / II large cell lymphoma ( intermediate grade in the Working Formulation ) were treated with irradiation alone , with overall cure rates of 40%-50 % .", "label": "", "metadata": {}, "score": "63.65735"}
{"text": "Initial disease was in the lower limb in 36 patients , in the upper limb in seven , and axial in two .Disease was localised in 33 patients .", "label": "", "metadata": {}, "score": "63.663727"}
{"text": "Two of these factors also predicted for poor PFS ( extranodal disease at time of first relapse and presence of mediastinal mass at time of transplantation ) .", "label": "", "metadata": {}, "score": "63.792732"}
{"text": "The median time to PFS was 8.8 months ( 95 % confidence interval ( CI 95 % ) , 2.3 to 15.3 ) .At the time of analysis , the median follow - up was 133.7 months ( range from 66.3 to 205.7 ) .", "label": "", "metadata": {}, "score": "63.798565"}
{"text": "However , 50 % of patients ultimately relapse after autotransplant which poses a big challenge .Allogeneic stem cell transplantation offers the only chance of cure in these patients .", "label": "", "metadata": {}, "score": "63.809208"}
{"text": "[ 1 ] Because of the rich submucosal lymphatic network of the nasopharynx , NPC has a propensity for early cervical node metastases .[ 2 ] A retrospective study showed that up to 40 % had nodal recurrence if the neck irradiation was withheld in patients without clinically palpable cervical nodes .", "label": "", "metadata": {}, "score": "63.819256"}
{"text": "Hurd DD , Haake RJ , Lasky LC , et al : Treat- ment of refractory and relapsed Hodgkin 's dis- ease : Intensive chemotherapy and autologous bone marrow or peripheral blood stem cell sup- port .", "label": "", "metadata": {}, "score": "63.850613"}
{"text": "The 3DCRT group was treated between 1999 and 2005 .Dose calculation was performed on Pinnacle planning system ( Philips Medical Systems ) for a linear accelerator ( Clinac 2100C , Varian Medical Systems ) .", "label": "", "metadata": {}, "score": "63.915676"}
{"text": "2339 - 2387 , Lippincott Williams & Wilkins , Philadelphia , Pa , USA , 6th edition , 2001 .View at Google Scholar .N. Schmitz , B. Pfistner , M. Sextro et al . , \" Aggressive conventional chemotherapy compared with high - dose chemotherapy with autologous haemopoietic stem - cell transplantation for relapsed chemosensitive Hodgkin 's disease : a randomised trial , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "63.940376"}
{"text": "J Clin Oncol 6:1845 - 1850 , 1988 45 .Robinson B , Kingston J , Nogueira Costa R , et al : Chemotherapy and irradiation in childhood Hodgkin 's disease .", "label": "", "metadata": {}, "score": "64.03499"}
{"text": "This is because with HCRT even complex target volumes such as the tumor bed of the costodiaphragmatic recess or the pericardium can be treated without or with little dose compromise and at the same time with optimal sparing of the normal tissue due to a steeper dose fall - off .", "label": "", "metadata": {}, "score": "64.11388"}
{"text": "The adult experiencerecommendsAHSCTatthefirstsignofprogres- sion after initial treatment with seven- or eight - drug regimens,34,69 - 71ratherthanaftersecondandthirdretrieval regimens .Thisrecommendationisbasedonpoorcurerates withadditionalconventionalchemotherapyregimensanda lower cumulative toxicity of immediate AHSCT .", "label": "", "metadata": {}, "score": "64.12256"}
{"text": "222 - 240 , 1971 .View at Google Scholar \u00b7 View at Scopus .J. P. Jouet , B. Buchet - Bouverne , P. Fenaux et al . , \" Influence of pregnancy on the activity of Hodgkin 's disease ? \"", "label": "", "metadata": {}, "score": "64.14783"}
{"text": "Further investigation is now required to determine the optimal timing of AHSCT , as well as to develop alternative regimens for those patients with factors prognostic for poor outcome after AHSCT .", "label": "", "metadata": {}, "score": "64.15381"}
{"text": "fTBI dose was 12 Gy delivered to the midplane using a linear acceleratorin10fractionsof1.2Gygivenover4days .Fiftypercent partialtransmissionpulmonaryblockswereused .Electronboosts of 6 Gy were given to the anterior and posterior ribs in two 3-Gy fractions to administer a midplane lung dose of less than 7.2 Gy .", "label": "", "metadata": {}, "score": "64.20151"}
{"text": "Horning SJ , Negrin RS , Chao JC , et al : Fractionated total - body irradiation , etoposide , and cyclophosphamide plus autografting in Hodgkin'sdisease and phoma .", "label": "", "metadata": {}, "score": "64.221176"}
{"text": "Late relapses after AHSCT have also beenreportedbyothers.15,24,34,43,45Thesefindingsemphasize theimportanceofcloselong - termfollow - upafterAHSCT .Data from the pediatric literature reveal severaladditionalprognosticfactorsforpooroutcomeafter AHSCT ( lactate dehydrogenase ratio of more than 1,31in- terval from diagnosis to AHSCT of ? 15 months,31and female sex29,62 ) .", "label": "", "metadata": {}, "score": "64.311295"}
{"text": "S37-S40 , 1998 .View at Google Scholar \u00b7 View at Scopus .B. Hagen , F. Walseth , and R. A. Walstad , \" Single and repeated dose pharmacokinetics of thio - TEPA in patients treated for ovarian carcinoma , \" Cancer Chemotherapy and Pharmacology , vol .", "label": "", "metadata": {}, "score": "64.3189"}
{"text": "J Clin Oncol 6:940 - 946 , 1988 34 .Phillips GL , Wolff SN , Herzig RH , et al : Treatment of progressive Hodgkin 's disease with intensive chemoradiotherapy and autolo- gous bone marrow transplantation .", "label": "", "metadata": {}, "score": "64.35452"}
{"text": "Conclusion .In France , high dose thiotepa with PBSC rescue is proposed for the treatment of osteosarcoma relapses .In a population of patients with well - known poor prognosis , we observed a radiological response rate of 31 % and 5-year OS of 31 % .", "label": "", "metadata": {}, "score": "64.3744"}
{"text": "Introduction .Osteosarcoma relapse has a poor prognosis , with less than 25 % survival at 5 years .We describe the experience of the French Society of Paediatric Oncology ( SFCE ) with high dose ( HD ) thiotepa and autologous stem cell transplantation ( ASCT ) in 45 children with relapsed osteosarcoma .", "label": "", "metadata": {}, "score": "64.459984"}
{"text": "However , the IDA - FLAG regimen achieved in 6/10 patients with refractory AML or with very early relapses a CR with a duration of 3 - 34 months ( median 11\u00b75 months ) ; three of them are alive in continuous CR , two after BMT or PBSCT .", "label": "", "metadata": {}, "score": "64.60774"}
{"text": "26 , pp .6379 - 6381 , 2012 .View at Publisher \u00b7 View at Google Scholar . A. K. Gopal , R. Ramchandren , O. A. O'Connor , et al . , \" Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation , \" Blood , vol .", "label": "", "metadata": {}, "score": "64.698235"}
{"text": "Treatment .Figure 1 summarizes the treatment schedule .Patients diagnosed with relapse or progression of osteosarcoma underwent treatment with or without conventional chemotherapy according to the practices of each centre and in accordance with the French recommendation for the treatment of recurrent osteosarcomas published in 1994 [ 7 ] .", "label": "", "metadata": {}, "score": "64.7146"}
{"text": "10.1016/j.ijrobp.2009.11.006 View Article PubMed .Baldini EH , Recht A , Strauss GM , DeCamp MM Jr , Swanson SJ , Liptay MJ , Mentzer SJ , Sugarbaker DJ : Patterns of failure after trimodality therapy for malignant pleural mesothelioma .", "label": "", "metadata": {}, "score": "64.7854"}
{"text": "6 , pp .1124 - 1133 , 1997 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .I. Glimelius , D. Molin , R. M. Amini , A. Gustavsson , B. Glimelius , and G. Enblad , \" Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB , \" European Journal of Haematology , vol .", "label": "", "metadata": {}, "score": "64.7869"}
{"text": "Jones RJ , Piantadosi S , Mann RB , et al : High - dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin 's disease .", "label": "", "metadata": {}, "score": "64.78812"}
{"text": "Therapy regimens for very late relapse HL are warranted to minimize complications .Introduction .With MOPP / ABVD or ABVD regimens more than 70 % of patients with Hodgkin 's lymphoma ( HL ) can effectively be cured .", "label": "", "metadata": {}, "score": "64.88704"}
{"text": "Some undergo intensification with TTP , often because of an apparent chemosensitivity .PBSC harvesting by leukapheresis was performed according to each centre 's standard procedure .", "label": "", "metadata": {}, "score": "64.94824"}
{"text": "REFERENCES 1 .Hudson MM , Greenwald C , Thompson E , et al : Efficacy and toxicity of multiagent chemo- therapy and low - dose involved - field radiotherapy in children and adolescents with Hodgkin 's dis- ease .", "label": "", "metadata": {}, "score": "64.97475"}
{"text": "Reece DE , Barnett MJ , Connors JM , et al : Intensive chemotherapy mide , carmustine , and etoposide followed by autologous bone marrow transplantation for re- lapsed Hodgkin 's disease .", "label": "", "metadata": {}, "score": "65.00871"}
{"text": "Buzaid AC , Lippman SM , Miller TP : Sal- vage therapy of advanced Hodgkin 's disease : Lieskovsky et al 4538 JOURNAL OF CLINICAL ONCOLOGY Downloaded from jco.ascopubs.org on October 21 , 2015 .", "label": "", "metadata": {}, "score": "65.03427"}
{"text": "Longo DL , Duffey PL , Young RC , et al : Conventional - dose salvage combination chemo- therapy in patients relapsing with Hodgkin 's dis- ease after combination chemotherapy : The low probability for cure .", "label": "", "metadata": {}, "score": "65.073425"}
{"text": "These superbresultshavenotbeenmatchedbyotherinvestigations .These studies , as well as our data , suggest that a small butsignificantnumberofpatientswhorelapseafterAHSCT are effectively treated with additional retrieval therapy .However , the majority of these patients will ultimately suc- cumbtotheirdisease .", "label": "", "metadata": {}, "score": "65.12668"}
{"text": "Page 5 .651 IDA - FLAG , a Relapse Therapy for Childhood AML ?1998 Blackwell Science Ltd , British Journal of Haematology 102 : 647 - 655 of follow - up ( 31 December 1997 ) and was 10\u00b75 months ( range 1 - 46 months ) .", "label": "", "metadata": {}, "score": "65.240204"}
{"text": "Adverse events related to the irradiation are listed in Table 2 . DISCUSSION .Our results confirmed the hypothesis that the probability of lower neck occult metastases by subclinical nodes was extremely low in patients who had node - negative NPC , and the omission of the lower neck during prophylactic node irradiation did not decrease the rate of lower neck control .", "label": "", "metadata": {}, "score": "65.27872"}
{"text": "Reece DE , Connors JM , Spinelli JJ , et al : Intensive therapy with cyclophosphamide , car- mustine , etoposide ? /- cisplatin , and autologous bone marrow transplantation for Hodgkin 's dis- ease in first relapse after combination chemo- therapy .", "label": "", "metadata": {}, "score": "65.33016"}
{"text": "[ 18 ] Likewise , Hashmi et al .treated 12 refractory or relapsed acute leukemia patients with FLAG - IDA regimen .\" [ Show abstract ] [ Hide abstract ] ABSTRACT : Oncologists today are greatly concerned about the treatment of relapsed / refractory acute leukemia .", "label": "", "metadata": {}, "score": "65.338974"}
{"text": "6 , pp .535 - 540 , 1998 .View at Google Scholar \u00b7 View at Scopus . E. L. Kaplan and P. Meier , \" Nonparametric estimation from incomplete observations , \" Journal of the American Statistical Association , vol .", "label": "", "metadata": {}, "score": "65.38496"}
{"text": "Salvage therapy consisted of chemotherapy and 50 patients received high - dose chemotherapy with autologous stem cell transplantation .Radiotherapy was performed in 29 cases , tandem autologous transplantation in five and allograft in three .", "label": "", "metadata": {}, "score": "65.39646"}
{"text": "Excluded were patients showing pre - existing severe life - threatening organ insuffi- ciencies ( renal , cardiac , pulmonary or hepatic failure ) or infections(septicshockormultiorganfailure , W.H.O.scale4 ) .", "label": "", "metadata": {}, "score": "65.43533"}
{"text": "Gemcitabine in combination with vinorelbine has been tested in a limited number of patients with HL after ASCT , with an encouraging response rate ( 75 % , 6 of 8 patients ) [ 28 ] .", "label": "", "metadata": {}, "score": "65.49577"}
{"text": "Reece DE , Barnett MJ , Shepherd JD , et al : High - dosecyclophosphamide , carmustine(BCNU ) , and etoposide ( VP16 - 213 ) with or without cisplatin ( CBV ? /- P ) and autologous transplantation for patients with Hodgkin 's disease who fail to enter a complete remission after combination chemother- apy .", "label": "", "metadata": {}, "score": "65.542046"}
{"text": "Lee AWM , Sham JST , Poon YF , et al .Treatment of stage I nasopharyngeal carcinoma : analysis of the patterns of relapse and the results of withholding elective neck irradiation .", "label": "", "metadata": {}, "score": "65.726074"}
{"text": "View at Google Scholar .R. Little , R. E. Wittes , D. L. Longo , and W. H. Wilson , \" Vinblastine for recurrent Hodgkin 's disease following autologous bone marrow transplant , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "65.84872"}
{"text": "1998 Blackwell Science Ltd , British Journal of Haematology 102 : 647 - 655 adults produced CR rates of 50 - 60 % ( Estey et al , 1994 ; Visani et al , 1994 ; Clavio et al , 1996 ) .", "label": "", "metadata": {}, "score": "65.86809"}
{"text": "Hema- tology / Oncology Clinics of North America , 7 , 81 - 107 .Kantarjian , H.M. , Estey , E.H. & Keating , M.A. ( 1996 ) New chemotherapeutic agents in acute myeloid leukemia .", "label": "", "metadata": {}, "score": "65.9932"}
{"text": "Abbreviation : HCRT : Highly conformal modulated radiotherapy , 3DCRT : 3-dimensional conformal radiotherapy .In the 3DCRT group 24 patients ( 96 % ) died of progressive disease and one of septic shock ( 4 % ) .", "label": "", "metadata": {}, "score": "66.041885"}
{"text": "Overall survival ( OS ) was measured from the date of the very late relapse to the last visit or death .Failure - free survival ( FFS ) was calculated from the date of very late relapse until documented relapse from CR after salvage therapy , disease progression following incomplete response to salvage therapy , or death , whatever came first .", "label": "", "metadata": {}, "score": "66.15622"}
{"text": "Friedmann AM , Hudson MM , Weinstein HJ , et al : Treatment of unfavorable childhood Hodgkin 's disease with VEPA and low - dose , involved - field radiation .", "label": "", "metadata": {}, "score": "66.18263"}
{"text": "Thiotepa has pharmacokinetic properties that favour the use of dose intensification .With reinjection of stem cell rescue to overcome its myelotoxicity , the MTD of TTP has been multiplied 15 times to reach 900 mg / m 2 in adults and children [ 31 - 33 ] .", "label": "", "metadata": {}, "score": "66.18382"}
{"text": "Firstly , the size of the volume to be treated is large , and may cover up to six liters .Secondly , the target lies in close proximity to various organs at risk ( OAR ) such as the heart , ipsilateral kidney , liver , remaining lung , esophagus and/or spinal cord .", "label": "", "metadata": {}, "score": "66.279785"}
{"text": "Patients and Methods .Patients .Between 1992 and 2004 , 53 patients with relapsed or refractory osteosarcomas were treated with high dose TTP ( 900 mg / m 2 ) followed by reinjection of autologous peripheral blood stem cells ( PBSC ) .", "label": "", "metadata": {}, "score": "66.339355"}
{"text": "Systemic chemotherapy is often used as a salvage option in patients with RR - HL failing ASCT .However the downside with these regimens includes modest response rates and shorter duration of response ranging from 6 to 8 months .", "label": "", "metadata": {}, "score": "66.35862"}
{"text": "Previous publications showed that highly conformal radiotherapy ( HCRT ) such as intensity modulated radiotherapy ( IMRT ) or volumetric modulated arc therapy ( VMAT ) can improve the dose distribution in respect to target coverage and dose to OAR [ 7 , 8 ] .", "label": "", "metadata": {}, "score": "66.37871"}
{"text": "Relapsed low grade lymphoma .In general , treatment with standard agents rarely produces a cure in patients whose disease has relapsed .Favorable survival after relapse has been associated with : .", "label": "", "metadata": {}, "score": "66.39836"}
{"text": "Characteristics n / range N Age Sex ( female / male ) FAB type / morphological classification M1 M2 M4 M5 M7 Biphenotypic leukaemia CMML in leukaemic transformation Disease stage Refractory First relapse Second relapse Secondary CNS involvement Duration First remission ?", "label": "", "metadata": {}, "score": "66.44396"}
{"text": "Clinical series have shown improvement in freedom from relapse only , with no significant difference in long - term survival .Adjuvant chemotherapy .The issue of whether adjuvant chemotherapy improves the prognosis of patients with early - stage low - grade NHL remains unresolved .", "label": "", "metadata": {}, "score": "66.52025"}
{"text": "Burns LJ , Daniels KA , McGlave PB , et al : Autologous stem cell transplantation for refrac- tory and relapsed Hodgkin 's disease : Factors predictive of prolonged survival .", "label": "", "metadata": {}, "score": "66.52079"}
{"text": "This exceptionally low neck relapse rate might be partly due to the 10-Gy boost to the suspicious nodes , which could have improved the treatment of subclinical disease .", "label": "", "metadata": {}, "score": "66.57109"}
{"text": "The durability of the second remission may be short , and clinical trials , such as bone marrow transplantation , should be considered .Intermediate to high grade lymphoma .", "label": "", "metadata": {}, "score": "66.62225"}
{"text": "Longo DL , Young RC , Wesley M , et al : Twenty years of MOPP therapy for Hodgkin 's disease .J Clin Oncol 4:1295 - 1306 , 1986 12 .", "label": "", "metadata": {}, "score": "66.623474"}
{"text": "Although the feasibility of RIC Allo - SCT has improved , there is still a lack of durable response and the high relapse or progression rates remain unsolved problems .", "label": "", "metadata": {}, "score": "66.666626"}
{"text": "From both the radiographic and histological responses , these results provide evidence that TTP could be considered an active drug for the treatment of osteosarcomas .", "label": "", "metadata": {}, "score": "66.826805"}
{"text": "2447 - 2451 , 1994 .View at Google Scholar \u00b7 View at Scopus .P. J. Coates , G. Slavin , and A. J. D'Ardenne , \" Persistence of Epstein - Barr virus in Reed - Sternberg cells throughout the course of Hodgkin 's disease , \" Journal of Pathology , vol .", "label": "", "metadata": {}, "score": "66.86859"}
{"text": "Recurrences of Hodgkin 's Lymphoma ( HL ) 5 years after the initial therapy are rare .The aim of this study is to report a single centre experience of the clinical characteristics , outcome , and toxicity of pts who experienced very late relapses , defined as relapses that occurred 5 or more years after the achievement of first complete remission .", "label": "", "metadata": {}, "score": "66.88072"}
{"text": "Wolden SL , Lamborn KR , Cleary SF , et al : Second cancers following pediatric Hodgkin 's disease .J Clin Oncol 16:536 - 544 , 1998 69 .", "label": "", "metadata": {}, "score": "66.992615"}
{"text": "The authors declare that they have no competing interests .Authors ' contributions .JK , PD and OR were responsible for the study design and implementation .", "label": "", "metadata": {}, "score": "67.07536"}
{"text": "Lenalidomide , an immunomodulatory drug , has emerged as a promising therapeutic option in patients with RR - HL .In a phase II study , 38 patients were treated with lenalidomide at a dose of 25 mg / day on days 1 - 21 of a 28-day cycle out of which 87 % patients had undergone prior stem cell transplantation .", "label": "", "metadata": {}, "score": "67.112724"}
{"text": "J Clin Oncol 1:432 - 439 , 1983 6 .Bonadonna G , Viviani S , Valagussa P , et al : Third - line salvage chemotherapy in Hodgkin 's disease .", "label": "", "metadata": {}, "score": "67.14211"}
{"text": "Hudson MM , Donaldson SS : Treatment of pediatric Hodgkin 's lymphoma .Semin Hematol 36:313 - 323 , 1999 19 .Bierman PJ , Anderson JR , Freeman MB , et al : High - dose chemotherapy followed by au- tologous hematopoietic rescue for Hodgkin 's disease patients following first relapse after che- motherapy .", "label": "", "metadata": {}, "score": "67.15191"}
{"text": "Cytogenetic abnormalities .2;q ? ; q ? ; p13 ) 47 , xy , t(9;11)(p21;q23 ) , \u00fe8 12 14 21 22 23 FAB : French - American - British classification .", "label": "", "metadata": {}, "score": "67.202385"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. H. Kirschbaum , B. H. Goldman , J. M. Zain et al . , \" A phase 2 study of vorinostat for treatment of relapsed or refractory Hodgkin lymphoma : Southwest Oncology Group Study S0517 , \" Leukemia and Lymphoma , vol .", "label": "", "metadata": {}, "score": "67.26888"}
{"text": "Distant metastases were diagnosed based on symptoms , physical examination , and imaging methods as described above .Adverse events were evaluated according to the Common Terminology Criteria for Adverse Events ( CTCAE version 3.0 ) .", "label": "", "metadata": {}, "score": "67.31355"}
{"text": "Leukemia , 10 , 600 - 608 .Journal of Clinical Oncology , 13 , 11 - 18 .Cancer Research , 50 , 7226 - 7231 .", "label": "", "metadata": {}, "score": "67.32195"}
{"text": "Diehl V , Mauch PM , Harris NL : Hodgkin 's disease , in DeVita VT Jr , Hellman S , Rosenberg SA ( eds ) : Cancer : Principles and Practice of On- cology ( ed 6 ) .", "label": "", "metadata": {}, "score": "67.358635"}
{"text": "2mg/100mLandAST / ALT ? normal , unlesstherewas radiographic or biopsy evidence of involvement with HD ) , and renal function ( serum creatinine ? 1.5mg/100 mL ) .", "label": "", "metadata": {}, "score": "67.38565"}
{"text": "EBV Specific CTL Therapy .Nearly 30 - 40 % of HL patients are known to be EBV positive , making the use of EBV - targeted therapy an attractive option .", "label": "", "metadata": {}, "score": "67.44059"}
{"text": "60 % complete remission rate , 25 % Relapse free survival at 4years .CVP .( cyclophosphamide , vincristine , and prednisone ) . C(M)OPP . cyclophosphamide + vincristine + procarbazine + prednisone .", "label": "", "metadata": {}, "score": "67.52832"}
{"text": "Verdeguer A , Pardo N , Madero L , et al : Autologous stem cell transplantation for ad- vanced Hodgkin 's disease in children .Bone Mar- row Transplant 25:31 - 34 , 2000 31 .", "label": "", "metadata": {}, "score": "67.54904"}
{"text": "Anselmo AP , Meloni G , Cavalieri E , et al : Conventional salvage chemotherapy vs. high- dose therapy with autografting for recurrent or refractory Hodgkin 's disease patients .", "label": "", "metadata": {}, "score": "67.596985"}
{"text": "Stahnke , K. , Ritter , J. , Schellong , G. , Beck , J.D. , Kabisch , H. , Lampert , F. & Creutzig , U. ( 1992 )", "label": "", "metadata": {}, "score": "67.60216"}
{"text": "Various novel agents have shown promising results but the duration of response is short lived .A standard approach to deliver the most effective treatment for these patients is still lacking .", "label": "", "metadata": {}, "score": "67.65694"}
{"text": "Page 5 . part of the high - dose therapy regimen .The third patient diedofinterstitialpneumonitis / Legionellapneumoniaafter having received mediastinal radiation as part of secondary combined - modality therapy as well as CCNU as part of the high - dose therapy regimen .", "label": "", "metadata": {}, "score": "67.71591"}
{"text": "Crump M , Smith AM , Brandwein J , et al : High - dose etoposide and melphalan , and autolo- gous bone marrow transplantation for patients with advanced Hodgkin 's disease : Importance of disease status at transplant .", "label": "", "metadata": {}, "score": "67.76587"}
{"text": "Both sites were affected by distant metastases in four further patients ( 40 % ) .Discussion .We demonstrate in a retrospective analysis of patients with MPM and treated at our institution with trimodality therapy that the use of postoperative highly conformal radiation techniques ( HCRT ) reduces local recurrence in comparison to 3DCRT .", "label": "", "metadata": {}, "score": "67.809006"}
{"text": "In addition , adults in their first relapseofHDhadsignificantlybetterfreedomfromtreatment failurewhentreatedwithBEAM - AHSCT .Theauthorsrecom- mendedhigh - dosechemotherapyandAHSCTforallpatients withHDinfirstrelapsewithchemosensitivedisease .Thereare multiple retrospective studies confirming the superiority of AHSCT compared with conventional therapy for adults with relapsedorrefractoryHD.56 - 58 Table 4 .", "label": "", "metadata": {}, "score": "67.81767"}
{"text": "Introduction .Hodgkin lymphoma ( HL ) is a potentially curable lymphoma with distinct histology , biologic behaviour , and clinical characteristics .The reported five - year event - free survival ranges between 80 and 90 % with combined modality chemotherapy and radiotherapy [ 1 ] .", "label": "", "metadata": {}, "score": "67.851494"}
{"text": "Statistical Methods End points analyzed were OS , EFS , and progression - free survival ( PFS ) calculated from time of AHSCT ( day 0 ) .", "label": "", "metadata": {}, "score": "67.863525"}
{"text": "Rooney CM , Bollard C , Huls MH , et al : Immunotherapy for Hodgkin 's disease .Ann He- matol 81:S39-S42 , 2002 ( suppl 2 ) 65 .", "label": "", "metadata": {}, "score": "67.872795"}
{"text": "Jagannath S , Armitage JO , Dicke KA , et al : Prognostic factors for response and survival after high - dose cyclophosphamide , carmustine , and etoposide with autologous bone marrow trans- plantation for relapsed Hodgkin 's disease .", "label": "", "metadata": {}, "score": "67.87769"}
{"text": "Alternative Strategies .For patients relapsing after allogeneic SCT , or those not suitable for allogeneic SCT , alternative therapeutic approaches include the use of monoclonal antibodies , conventional chemotherapeutic drugs , or novel agents ( Table 1 ) .", "label": "", "metadata": {}, "score": "67.90188"}
{"text": "Williams CD , Goldstone AH , Pearce R , et al : Autologous bone marrow transplantation for pediatric Hodgkin 's disease : A case - matched comparison with adult patients by the European Bone Marrow Transplant Group Lymphoma Reg- istry .", "label": "", "metadata": {}, "score": "67.920166"}
{"text": "Radiotherapy seems to be an important issue in preventing late relapse .Patients who relapse within the first 3 years have more aggressive disease , and patients who relapse late have a more indolent disease that responds to further therapy [ 21 , 22 ] .", "label": "", "metadata": {}, "score": "68.03663"}
{"text": "Gribben JG , Vaughan Hudson B , Linch DC : The potential value of very intensive therapy with autologous bone marrow rescue in the treat- ment of malignant lymphomas .", "label": "", "metadata": {}, "score": "68.04417"}
{"text": "The estimated FFS was 75 % at 5 years ( Figure 1 ) .Figure 1 : Overall survival and failure - free survival in 16 PTS with VLR HL .", "label": "", "metadata": {}, "score": "68.13673"}
{"text": "Leukemia and Lymphoma , 10 , ( Suppl . )Leukemia , 4 , 184 - 188 .Annals of Hematology , 73 , 265 - 271 .", "label": "", "metadata": {}, "score": "68.14363"}
{"text": "1522 - 1527 , 1981 .View at Google Scholar \u00b7 View at Scopus .S. Rodenhuis , M. Bontenbal , L. V. Beex , et al . , \" High - dose chemotherapy with hematopoietic stem - cell rescue for high - risk breast cancer , \" The New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "68.19982"}
{"text": "Panobinostat , is a potent pan - HDAC inhibitor and more potent than vorinostat in lymphoma preclinical models .A phase II study of panobinostat in RR - HL showed encouraging clinical activity with ORR 27 % , 5 patients achieving CR , and 30 patients achieving PR with median PFS of 6.1 months [ 36 ] .", "label": "", "metadata": {}, "score": "68.27371"}
{"text": "1522 - 1529 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. M. Smith , K. van Besien , J. Carreras et al . , \" Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant , \" Biology of Blood and Marrow Transplantation , vol .", "label": "", "metadata": {}, "score": "68.3896"}
{"text": "Analysis and examples , \" British Journal of Cancer , vol .35 , no . 1 , pp . 1 - 39 , 1977 .", "label": "", "metadata": {}, "score": "68.5473"}
{"text": "The clinical significance and natural history of this pattern of disease are not well defined .Progression to DLBC lymphoma at 5 % per year .", "label": "", "metadata": {}, "score": "68.56009"}
{"text": "Primary brain lymphomas continue to be problematic .At present , the recommended approach is chemotherapy , high - dose methotrexate ? other drugs that penetrate the CNS ( i.e. cytarabine [ Ara - C ] , procarbazine , vincristine , thiotepa [ Thioplex ] , temozolomide [ Temodar ] ) , in conjunction with radiation therapy .", "label": "", "metadata": {}, "score": "68.571"}
{"text": "7 - 12 , 1998 .View at Google Scholar \u00b7 View at Scopus .C. Kalifa , O. Hartmann , F. Demeocq et al . , \" High - dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors : a phase II study , \" Bone Marrow Transplantation , vol .", "label": "", "metadata": {}, "score": "68.62822"}
{"text": "J Appl Med Phys 2013 , 14 : 1 - 10 .Krayenbuehl J , Hartmann M , Lomax AJ , Kloeck S , Hug EB , Ciernik IF : Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy .", "label": "", "metadata": {}, "score": "68.73706"}
{"text": "Horning SJ , Chao NJ , Negrin RS , et al : High - dose therapy and autologous hematopoi- etic progenitor cell transplantation for recurrent or refractory Hodgkin 's disease : Analysis of the Stanford University results and prognostic indi- ces .", "label": "", "metadata": {}, "score": "68.76059"}
{"text": "Tipifarnib was well tolerated ; the main adverse effects were mainly myelosuppression .More studies are required to test its efficacy in RR - HL either as a single agent or in combination with other drugs [ 44 ] .", "label": "", "metadata": {}, "score": "68.88965"}
{"text": "Gastric or small intestinal lymphoma at high risk of perforation or life - threatening hemorrhage may require surgical resection .Alternatively , chemotherapy followed by local irradiation may allow gastric preservation in some patients .", "label": "", "metadata": {}, "score": "69.0045"}
{"text": "Even after trimodality treatment local recurrence remains high in some patient series .In a retrospective series of 49 patients treated with 3D - conformal RT after EPP and chemotherapy 67 % of all recurrences included the ipsilateral hemithorax and 25 % of all recurrences were local only [ 12 ] .", "label": "", "metadata": {}, "score": "69.07176"}
{"text": "Nademanee A , Sniecinski I , Schmidt GM , et al : High - dose therapy followed by autologous peripheral - blood stem - cell transplantation for pa- tients with Hodgkin 's disease and non - Hodgkin 's lymphoma using unprimed and granulocyte colony - stimulating factor - mobilized peripheral- non - Hodgkin'slym- blood stem cells .", "label": "", "metadata": {}, "score": "69.150375"}
{"text": "Leukemia , 8 , 1842 - 1846 .Leukemia , 6 , ( Suppl .Leukemia , 8 , 1626 - 1630 .Journal of Clinical Oncology , 12 , 2367 - 2377 .", "label": "", "metadata": {}, "score": "69.177925"}
{"text": "Durable responses to radiolabeled monoclonal antibodies , such as yttrium-90 ibritumomab ( commercially available ) and iodine-131 tositumomab , have also been reported ; subsequent chemotherapy regimens can be delivered at the time of relapse following radioimmunotherapy .", "label": "", "metadata": {}, "score": "69.185265"}
{"text": "For select patients , allogeneic stem - cell transplantation should be considered as a potentially curative approach .Radiotherapy .Irradiation therapy here is used locally for palliation of symptomatic sites of disease and is extremely effective .", "label": "", "metadata": {}, "score": "69.19391"}
{"text": "The prescribed dose was 70 Gy in 35 daily fractions to the nasopharynx and the surrounding risk tissues , and 50 Gy in 25 daily fractions to the upper neck .", "label": "", "metadata": {}, "score": "69.34704"}
{"text": "Estey , E. , Plunkett , W. , Gandhi , V. , Rios , M.B. , Kantarjian , H. & Keating , M.J. ( 1993 ) Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia .", "label": "", "metadata": {}, "score": "69.37471"}
{"text": "4 , pp .752 - 761 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. G. Huvos , G. Rosen , and R. C. Marcove , \" Primary osteogenic sarcoma .", "label": "", "metadata": {}, "score": "69.41356"}
{"text": "5 fTBI 12 ? 2 VP16 60 Cyclophosphamide 100 Abbreviations : BCNU , carmustine ; VP16 , etoposide ; CCNU , lomustine ; fTBI , fractionated total - body irradiation .", "label": "", "metadata": {}, "score": "69.48778"}
{"text": "Journal of Clinical Oncology , 7 , 1071 - 1080 .Kornblau , S.M. , Cortes Franco , J. & Estey , E. ( 1993 ) Neurotoxicity associated with fludarabine and cytosine arabinoside chemother- apy for acute leukemia and myelodysplasia .", "label": "", "metadata": {}, "score": "69.59042"}
{"text": "Allo - SCT offers the only chance of cure for suitable patients after failed ASCT ; however selecting the best conditioning regimen is still controversial .", "label": "", "metadata": {}, "score": "69.91489"}
{"text": "1998 Blackwell Science Ltd , British Journal of Haematology 102 : 647 - 655 648 G. Fleischhack et al .Page 3 .649 IDA - FLAG , a Relapse Therapy for Childhood AML ?", "label": "", "metadata": {}, "score": "70.002655"}
{"text": "A noninferiority design was used to test the hypothesis that for patients with node - negative NPC , prophylactic irradiation of the upper neck is not inferior to the irradiation of the whole - neck in terms of lower neck disease control .", "label": "", "metadata": {}, "score": "70.00327"}
{"text": "Patients were not selected for this review if they had metastatic disease or a local relapse before the start of RT .The study was approved by the local ethics committee of the University Hospital of Zurich .", "label": "", "metadata": {}, "score": "70.0289"}
{"text": "Pathologic staging , therefore , selected a group suitable for irradiation alone .Combined - modality therapy .Combined - modality therapy includes 3 cycles of CHOP in addition to irradiation .", "label": "", "metadata": {}, "score": "70.05145"}
{"text": "4 , pp .291 - 297 , 1991 .View at Google Scholar \u00b7 View at Scopus To evaluate the outcome of pediatric patients with refractory or relapsed Hodgkin 's disease ( HD ) who undergo high - dose therapy and autologous hematopoietic stem - cell transplantation ( AHSCT ) .", "label": "", "metadata": {}, "score": "70.10887"}
{"text": "Duration of initial remission , months Median Range Presence of \" B \" symptoms at first relapse Chemotherapy before cytoreduction No . of drugs Median Range No .", "label": "", "metadata": {}, "score": "70.12407"}
{"text": "Department of Statistics , Jiangxi Cancer Hospital , Nanchang , China .Department of Oncology , First Affiliated Hospital of Gannan Medical College , Ganzhou , China .", "label": "", "metadata": {}, "score": "70.13609"}
{"text": "View at Google Scholar \u00b7 View at Scopus .N. Lucidarme , D. Valteau - Couanet , O. Oberlin et al . , \" Phase II study of high - dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors , \" Bone Marrow Transplantation , vol .", "label": "", "metadata": {}, "score": "70.14822"}
{"text": "12 , pp .2614 - 2620 , 1994 .View at Google Scholar \u00b7 View at Scopus .J. Hara , Y. Osugi , H. Ohta et al . , \" Double - conditioning regimens consisting of thiotepa , melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors , \" Bone Marrow Transplantation , vol .", "label": "", "metadata": {}, "score": "70.16803"}
{"text": "Armitage JO , Bierman PJ , Vose JM , et al : Autologous bone marrow transplantation for pa- tients with relapsed Hodgkin 's disease .Am J Med 91:605 - 611 , 1991 54 .", "label": "", "metadata": {}, "score": "70.22633"}
{"text": "Behrendt H , Van Bunningen BN , Van Leeuwen EF : Treatment of Hodgkin 's disease in children with or without radiotherapy .Cancer 59:1870 - 1873 , 1987 44 .", "label": "", "metadata": {}, "score": "70.253235"}
{"text": "Patient Eligibility .This study was approved by the ethics committee of our hospital , and informed consent was obtained from each patient before their entry into the study .", "label": "", "metadata": {}, "score": "70.31708"}
{"text": "HCRT has been used at our institution since 2005 for the treatment of MPM patients .Of the 14 patients treated with HCRT , 11 were treated with conventional static field IMRT and 3 patients with rotational IMRT ( volumetric arc radiotherapy , i.e. Rapid Arc \u00ae in the present series ) .", "label": "", "metadata": {}, "score": "70.340485"}
{"text": "Klinische Pa \u00a8diatrie , 205 , 217 - 224 .Leukemia , 6 , ( Suppl .Journal of ClinicalOncology , 5 , 1022 - 1025 .", "label": "", "metadata": {}, "score": "70.35234"}
{"text": "10.1016/j.ijrobp.2007.07.2370 View Article PubMed .Allen AM , Schofield D , Hacker F , Court LE , Czerminska M : Restricted field IMRT dramatically enhances IMRT planning for mesothelioma .", "label": "", "metadata": {}, "score": "70.37348"}
{"text": "In this phase II study , bendamustine was administered at a dose of 120 mg / m 2 for two consecutive days , every 28 days , for up to maximum of 6 cycles .", "label": "", "metadata": {}, "score": "70.39784"}
{"text": "The present study has evaluated mortality and response rate of this regimen .In this study , 25 patients with refractory / relapsed acute leukemia aged 15 - 55 years underwent FLANG regimen at Seyed - Al - Shohada Hospital , Isfahan , Iran during 2008 - 2009 .", "label": "", "metadata": {}, "score": "70.39848"}
{"text": "Although carefully collected , accuracy can not be guaranteed .The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .", "label": "", "metadata": {}, "score": "70.40222"}
{"text": "Submitted February 18 , 2004 ; accepted August 30 , 2004 .Presented abstract at the 45th Annual Meeting of the American Society for Therapeutic Radiology and Oncology , Salt Lake City , UT , October 21 , 2003 .", "label": "", "metadata": {}, "score": "70.44404"}
{"text": "10.1016/j.thorsurg.2004.06.006 View Article PubMed .Krayenbuehl J , Susann O , Davis JB , Ciernik IF : Combined Photon and Electron 3D - Conformal versus Intensity Modulated Radiotherapy with an Integrated Boost for Adjuvant Treatment of Malignant Pleural Mesothelioma following Pleuropneumonectomy .", "label": "", "metadata": {}, "score": "70.47641"}
{"text": "View at Google Scholar \u00b7 View at Scopus .S. Rodenhuis , A. Westermann , M. J. Holtkamp et al . , \" Feasibility of multiple courses of high - dose cyclophosphamide , thiotepa , and carboplatin for breast cancer or germ cell cancer , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "70.53053"}
{"text": "Because the aforementioned study showed that more than 95 % of recurrent node disease occurred in the upper neck region , the omission of UNI would certainly result in a higher rate of regional relapse .", "label": "", "metadata": {}, "score": "70.54574"}
{"text": "Lung complications such as radiation pneumonitis are likely to be higher with multi - field techniques such as IMRT or VMAT in comparison to 3DCRT , where opposed beams from 0 and 180 degrees are usually used , thereby optimally sparing the contralateral lung .", "label": "", "metadata": {}, "score": "70.70611"}
{"text": "Conclusion .The use of HD thiotepa and ASCT is feasible in patients with relapsed osteosarcoma .A randomized study for recurrent osteosarcoma between standard salvage chemotherapy and high dose thiotepa with stem cell rescue is ongoing .", "label": "", "metadata": {}, "score": "70.76419"}
{"text": "6 , pp .1071 - 1079 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. de Filippi , D. Aldinucci , D. Galati , et al . , \" Effects of bendamustine on apoptosis and colony - initiating precursors in Hodgkin lymphoma cells , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "70.813"}
{"text": "For calculation of EFS , we defined an adverse event as either relapseofHD , developmentofasecondmalignancy , ordeath .For calculation of PFS , we defined an event as relapse of HD ( with non - HD - related deaths censored ) . .10 weredeterminedforthethreeendpointsofinterest .", "label": "", "metadata": {}, "score": "71.00702"}
{"text": "Reece DE , Phillips GL : Intensive therapy and autologous stem cell transplantation for Hodgkin 's disease in first relapse after combina- tion chemotherapy .Leuk Lymphoma 21:245- 253 , 1996 27 .", "label": "", "metadata": {}, "score": "71.038345"}
{"text": "The study was conducted in accordance with the updated Declaration of Helsinki and approved by the local ethics committee of the University of Bonn .Prior to enrolment in the study all patients ' parents and/or the patients were informed about the investigational character of the study , the potential risks of this regimen as well as the poor prognosis of relapsed , refractoryor secondary AML , and gave their consent to treatment .", "label": "", "metadata": {}, "score": "71.07217"}
{"text": "Horning SJ , Rosenberg SA , Hoppe RT : Brief chemotherapy ( Stanford V ) and adjuvant radiotherapy for bulky or advanced Hodgkin 's disease : An update .", "label": "", "metadata": {}, "score": "71.088394"}
{"text": "Patients were entered onto one of fourconsecutiveautologoustransplantationprotocolsatStanford University Hospital and/or Lucile Salter Packard Children 's Hos- pital at Stanford between September 5 , 1989 , and December 31 , 2001 .", "label": "", "metadata": {}, "score": "71.12897"}
{"text": "For the FLAG courses the duration of myelo- suppression was clearly shorter than for the IDA - FLAG courses .Treatment response to IDA - FLAG / FLAG regimen .", "label": "", "metadata": {}, "score": "71.27378"}
{"text": "238 - 244 , 2013 .View at Publisher \u00b7 View at Google Scholar Update on Salvage Options in Relapsed / Refractory Hodgkin Lymphoma after Autotransplant . 1 Department of Medical Oncology , Dr. B. R. A. Institute Rotary Cancer Hospital , All India Institute of Medical Sciences , New Delhi 110029 , India 2 Department of Anaesthesia and Intensive Care Unit , Indraprastha Apollo Hospital , New Delhi 110076 , India .", "label": "", "metadata": {}, "score": "71.305244"}
{"text": "Recurrence adjacent to the field border but not in - field was defined as marginal miss recurrence .Regional recurrence was defined as recurrence in close proximity but not within the irradiated field .", "label": "", "metadata": {}, "score": "71.450485"}
{"text": "The response rate for ibritumomab tiuxetan was 80 % and complete response ( confirmed and unconfirmed ) was seen in 34 % of patients , whereas for rituximab , it was 56 % and 20 % .", "label": "", "metadata": {}, "score": "71.478"}
{"text": "Kaplan EL , Meier P : Nonparametric esti- mation from incomplete observations .J Am Stat Assoc 53:457 - 481 , 1958 41 .Cox DR : Regression models and life ta- bles .", "label": "", "metadata": {}, "score": "71.572464"}
{"text": "Localized MALT marginal zone gastric lymphoma that does not respond to antibiotics may be cured with local irradiation , consisting of 30 Gy in 1.5-Gy daily fractions directed to the stomach and perigastric lymph nodes .", "label": "", "metadata": {}, "score": "71.57954"}
{"text": "Lieskovsky et al 4534 JOURNAL OF CLINICAL ONCOLOGY Downloaded from jco.ascopubs.org on October 21 , 2015 .For personal use only .No other uses without permission .", "label": "", "metadata": {}, "score": "71.59856"}
{"text": "Special types of aggressive disease .Disease site or potential toxicities may influence the treatment plan : .In younger patients , a brief period of chemotherapy ( 3 - 4 cycles of CHOP ) followed by local irradiation may be used to prevent sterility in men and early menopause in women .", "label": "", "metadata": {}, "score": "71.6584"}
{"text": "Few patients with documented very late relapses have been closely analyzed in the literature [ 17 - 31 ] .Patients and Methods .From 1985 to 1999 , 532 consecutive previously untreated patients with classical HL were evaluated and treated at the Hematology Department of the University of Bari , Italy .", "label": "", "metadata": {}, "score": "71.72342"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . S. B. Strum and H. Rappaport , \" The persistence of Hodgkin 's disease in long - term survivors , \" American Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "71.759995"}
{"text": "Results of 2 studies with longer follow - up periods were also reported recently .These results suggest that tumor control and survival are not adversely affected when the lower neck is omitted during WNI in the treatment of patients with N0 NPC .", "label": "", "metadata": {}, "score": "71.896614"}
{"text": "Hagemeister FB , Tannir N , McLaughlin P , et al : MIME chemotherapy ( methyl - GAG , ifos- famide , methotrexate , etoposide ) as treatment for recurrent Hodgkin 's disease .", "label": "", "metadata": {}, "score": "72.06377"}
{"text": "655 IDA - FLAG , a Relapse Therapy for Childhood AML ?1998 Blackwell Science Ltd , British Journal of Haematology 102 : 647 - 655 Loughlin , S. , Gandhi , V. , Plunkett , \u00a3 .", "label": "", "metadata": {}, "score": "72.07097"}
{"text": "MALT marginal zone lymphoma .Combination therapy ( eg , omeprazole [ Prilosec ] , metronidazole , and amoxicillin ) directed at the infection results in the regression of most early lesions .", "label": "", "metadata": {}, "score": "72.09233"}
{"text": "1998 Blackwell Science Ltd , British Journal of Haematology 102 : 647 - 655 652 G. Fleischhack et al Table V. Nonhaematological toxicities of the IDA - FLAG / FLAG regimen .", "label": "", "metadata": {}, "score": "72.18912"}
{"text": "The study was designed as an open comparative multicentre investigation and was started in February 1994 .The diagnosis of AML or of the leukaemic transformation in MDS was confirmed in all patients by bone marrow aspiration .", "label": "", "metadata": {}, "score": "72.20357"}
{"text": "Ann Oncol 2:9 - 16 , 1991 ( suppl 1 ) 13 .Bergsagel DE : Salvage treatment for Hodgkin 's disease in relapse .J Clin Oncol 5:525- 526 , 1987 14 .", "label": "", "metadata": {}, "score": "72.27379"}
{"text": "Leukemia and Lymphoma , 10 , ( Suppl . )Gandhi , V. , Estey , E. , Keating , M.J. & Plunkett , W. ( 1993b ) Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy .", "label": "", "metadata": {}, "score": "72.30556"}
{"text": "At the Table 1 .Patient Characteristics Characteristic No . of Patients ( N ?41)%Sex Male Female Age at transplantation , years Median Range Characteristics at diagnosis Histology Nodular sclerosing Lymphocyte predominant Mixed cellularity Disease stage at diagnosis I II III IV Initial presentation \" B \" symptoms Presence of bulky disease ?", "label": "", "metadata": {}, "score": "72.36778"}
{"text": "Patients with intermediate and unfavourable relapse should receive high - dose chemotherapy and ASCT when chemosensitive ; the first goal is to achieve this chemosensitivity .", "label": "", "metadata": {}, "score": "72.403015"}
{"text": "Radiation therapy .The treatment of choice is irradiation alone to the entire involved lymphoid region , as defined by the Rai and Ann Arbor staging classifications , or the involved region plus one additional uninvolved region on each side of the involved nodes .", "label": "", "metadata": {}, "score": "72.51659"}
{"text": "Overall survival was also significantly better with transplantation ( 53 % vs. 32 % ) .Salvage bone marrow transplantation was unsuccessful for patients on the nontransplant arm whose disease relapsed ( PARMA trial ) .", "label": "", "metadata": {}, "score": "72.5284"}
{"text": "Haematologica , 81 , 513 - 520 .( AML ) the and analysis Childrenof EORTC .Page 8 .Creutzig , U. , Ritter , J. , Zimmerman , M. , Riehm , H. & Schellong , G. ( 1995 ) Highlights of BFM schedule in childhood AML : AML - BFM Study Group .", "label": "", "metadata": {}, "score": "72.53082"}
{"text": "In addition , in a limited number of patients , better clinical responses were observed when fludarabine was administered prior to CTLs infusion [ 42 ] .", "label": "", "metadata": {}, "score": "72.654755"}
{"text": "Donaldson SS , Link MP : Combined modal- ity treatment with low - dose radiation and MOPP chemotherapy for children with Hodgkin 's dis- ease .", "label": "", "metadata": {}, "score": "72.695435"}
{"text": "Early treatment - related mortality was defined as death without recurrent HD within 100 days after transplantation .Late treatment - related mortality was defined as death without recur- rent HD greater than 100 days after transplantation .", "label": "", "metadata": {}, "score": "72.98896"}
{"text": "Santoro A , Bonfante V , Bonadonna G : Salvage chemotherapy with ABVD in MOPP- resistant Hodgkin 's disease .Ann Intern Med 96:139 -143 , 1982 5 .", "label": "", "metadata": {}, "score": "73.07156"}
{"text": "Stage III / IV disease .The following recommended treatment strategies should be adjusted according to the level of risk , as defined by the prognostic factors validated by the IPI : .", "label": "", "metadata": {}, "score": "73.11562"}
{"text": "All rights reserved .Page 4 . have been 16 deaths among the 41 patients , of which 11 were a result of progressive HD , and five were a result of treatment - related toxicity .", "label": "", "metadata": {}, "score": "73.247696"}
{"text": "Long - term freedom from second relapse , however , is uncommon and multiple relapses will usually occur .Bone marrow transplantation .Bone marrow transplantation is still under evaluation but should be considered in the context of a clinical trial .", "label": "", "metadata": {}, "score": "73.30354"}
{"text": "Ann Oncol 13:159 - 162 , 2002 ( suppl 4 ) 70 .Cavalli FG , Hansen HH , Kaye S ( eds ) : Text- book of Medical Oncology ( ed 2 ) .", "label": "", "metadata": {}, "score": "73.347725"}
{"text": "Primary therapy consisted in 11/20 patients in surgical resection and adjuvant radiotherapy , in 9/20 patients a definitive radio chemotherapy was carried out previously .For re - irradiation in all patients a three dimensional CT - based treatment planning was performed using the ABACUS brachytherapy planning system .", "label": "", "metadata": {}, "score": "73.36459"}
{"text": "Thiotepa is an alkylating agent with antitumour activity that has been used for 30 years to treat adult ovarian [ 27 ] and breast [ 28 , 29 ] cancers .", "label": "", "metadata": {}, "score": "73.38724"}
{"text": "J Clin Oncol 17:825- 831 , 1999 32 .Horning SJ : Primary refractory Hodgkin 's disease .Ann Oncol 9:S97-S101 , 1998 ( suppl 5 ) 33 .", "label": "", "metadata": {}, "score": "73.42229"}
{"text": "Further evaluation in a phase III trial is needed to determine the efficacy and toxicity in comparison to other reinduction therapies , especially those which contain high - dose ARA - C. Appreciation is also expressed for support from the companies Medac Hamburg , Amgen / Roche Mu \u00a8nchen and Pharmacia Erlangen .", "label": "", "metadata": {}, "score": "73.48955"}
{"text": "Good responders usually receive a second - line chemotherapy indicated for poor responders , and initial poor responders with multiple or unresectable metastases are treated with various second - line chemotherapy regimens in an attempt to allow complete surgery .", "label": "", "metadata": {}, "score": "73.5413"}
{"text": "View at Publisher \u00b7 View at Google Scholar .K. G. Lucas , D. Salzman , A. Garcia , and Q. Sun , \" Adoptive immunotherapy with allogeneic Epstein - Barr virus ( EBV)- specific cytotoxic T - lymphocytes for recurrent EBV - positive Hodgkin disease , \" Cancer , vol .", "label": "", "metadata": {}, "score": "73.59576"}
{"text": "Brentuximab was also found to enable some patients to proceed to allogeneic stem cell transplantation and did not adversely affect stem cell engraftment , graft versus host disease , or survival [ 19 ] .", "label": "", "metadata": {}, "score": "73.60115"}
{"text": "JK , PD , IC and OR contributed to the implementation and manuscript writing .All authors read and approved the final manuscript .Authors ' Affiliations .", "label": "", "metadata": {}, "score": "73.77643"}
{"text": "Infectious complications were more toxicities using theW.H.O.scale and cardiac complications frequent and severe in IDA - FLAG than in FLAG courses .Fever of unknown origin occurred during myelosuppression following 13/24 IDA - FLAG courses and 5/13 FLAG courses .", "label": "", "metadata": {}, "score": "73.78401"}
{"text": "Denileukin difitox , a fusion protein combining diptheria toxin and interleukin-2 , resulted in a 25 % objective response rate in 45 heavily pretreated patients with aggressive B - cell non - Hodgkin 's lymphoma ( CD25 , i.e. , interleukin-2 receptor , expression was not correlated with response ) .", "label": "", "metadata": {}, "score": "73.93338"}
{"text": "Radiolabelled antibodies ibritumomab tiuxetan ( Zevalin ) and tositumomab / iodine-131 have shown encouraging results .Interferon .The use of interferon ( IFN)-alfa ( Intron A , Roferon - A ) concomitantly with or as an adjuvant to conventional chemotherapy in follicular lymphoma appears to prolong disease - free survival , but its impact on overall survival and curability is controversial .", "label": "", "metadata": {}, "score": "73.99548"}
{"text": "Approaches to elderly patients should include interventions aimed at preserving or increasing dose intensity and improving tolerance of therapy with the use of cytokines and infusional chemotherapy .", "label": "", "metadata": {}, "score": "74.08325"}
{"text": "Hunger SP , Link MP , Donaldson SS : ABVD / MOPP and low - dose involved - field radio- therapy in pediatric Hodgkin 's disease : The Stan- ford experience .", "label": "", "metadata": {}, "score": "74.25516"}
{"text": "Klinische Pa \u00a8diatrie , 204 , 253 - 257 .Journal of Clinical Oncology , 14 , 1521 - 1525 .Tosi , P. , Visani , G. , Ottaviani , E. , Manfori , S. , Zinzani , P.L. & Tura , S. ( 1994 ) Fludarabine\u00feAra - C\u00feG - CSF : cytotoxic effect and induc- tion of apoptosis on fresh acute myeloid leukemia cells .", "label": "", "metadata": {}, "score": "74.417114"}
{"text": "Leukemia , 9 , 95 - 101 .Cancer , 67 , 2235 - 2240 .Plunkett , W. , Gandhi , V. , Huang , P. , Robertson , L.E. , Yang , L.Y. , Gregoire , V. , Estey , E. & Keating , M.J. ( 1993 ) Fludarabine : pharmacokinetics , mechanisms of action , and rationales for combination therapies .", "label": "", "metadata": {}, "score": "74.44545"}
{"text": "Lancet Oncol 2011 , 12 : 763 - 772 .10.1016/S1470 - 2045(11)70149 - 8 View Article PubMed Central PubMed .Janne PA , Baldini E : Patterns of failure following surgical resection for malignant pleural mesothelioma .", "label": "", "metadata": {}, "score": "74.657326"}
{"text": "As the armamentarium for the treatment of patients with RR - HL continues to expand , we would be left with more complexities than comforts .", "label": "", "metadata": {}, "score": "74.73449"}
{"text": "- 183X/04/2222 - 4532/$20.00 DOI : 10.1200/JCO.2004.02.121 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A LR E P O R T VOLUME22 ? NUMBER22 ? NOVEMBER152004 4532 Downloaded from jco.ascopubs.org on October 21 , 2015 .", "label": "", "metadata": {}, "score": "74.86755"}
{"text": "Older patients .Older patients with asymptomatic , indolent NHL are often observed closely without any initial therapy .The decision to use any of the standard or newer modalities should be individualized , based on the presence of poor prognostic features and the patient?s tolerance to planned therapy .", "label": "", "metadata": {}, "score": "74.95899"}
{"text": "17 , no . 9 , pp .423 - 427 , 1988 .View at Google Scholar \u00b7 View at Scopus .Leukemia and Lymphoma , vol .", "label": "", "metadata": {}, "score": "75.05483"}
{"text": "Autologous stem cell transplantation ( ASCT ) is the standard of care for patients with relapsed HL [ 3 ] .About half of all patients undergoing ASCT are rescued and definitely cured by such an approach , but the outcome of patients relapsing or refractory to second - line chemotherapy and ASCT is dismal , with a median survival of less than three years [ 4 ] .", "label": "", "metadata": {}, "score": "75.10695"}
{"text": "Rituximab results in a 40 % to 50 % response rate in patients who relapse with indolent B - cell lymphomas .Rituximab can also be combined with combination chemotherapy .", "label": "", "metadata": {}, "score": "75.27891"}
{"text": "Therefore , we have conducted this randomized clinical trial to verify our hypothesis that omitting the lower neck during prophylactic node irradiation will not significantly increase the rate of lower neck nodal relapse .", "label": "", "metadata": {}, "score": "75.42262"}
{"text": "10.1067/mtc.2001.116560 View Article PubMed .J Clin Oncol 2003 , 21 : 2636 - 2644 .10.1200/JCO.2003.11.136 View Article PubMed .Ann Oncol 2007 , 18 : 1196 - 1202 .", "label": "", "metadata": {}, "score": "75.586395"}
{"text": "Med Pediatr Oncol 18:482 - 486 , 1990 15 .Canellos GP : Is there an effective salvage therapy for advanced Hodgkin 's disease ?Ann Oncol 2:1 - 7 , 1991 ( suppl 1 ) 16 .", "label": "", "metadata": {}, "score": "75.765114"}
{"text": "No other uses without permission .Copyright \u00a9 2004 American Society of Clinical Oncology .All rights reserved .Page 6 . recurrence after primary therapy , with 5-year survival rates after conventional retrieval therapy of less than 20%.47The useofAHSCTforrelapsedandprimaryrefractoryHDafter combined - modality therapy in pediatric patients is be- coming the treatment of choice as transplantation - related mortalityratesdeclineanddurableresponseratesimprove .", "label": "", "metadata": {}, "score": "75.82463"}
{"text": "Bone marrow transplantation can be used in the setting of a clinical trial .Several randomized prospective trials evaluated the role of autologous bone marrow or stem cell transplantation consolidation versus chemotherapy alone in patients in first remission with diffuse large cell lymphoma .", "label": "", "metadata": {}, "score": "75.88139"}
{"text": "Rayappa , C. & McCulloch , E.A. ( 1993 )A cell culture model for the treatment of acute myeloblastic leukemia with fludarabine and cytosine arabinoside .", "label": "", "metadata": {}, "score": "75.975235"}
{"text": "Irradiation may be added if there is localized residual disease after chemotherapy completion to improve local control .Irradiation can also be delivered to prechemotherapy areas of bulky disease , again to enhance local control .", "label": "", "metadata": {}, "score": "76.02423"}
{"text": "The prognosis of refractory , relapsed or secondary AML is poor and effective reinduction regimens are rare .Allogeneic or autologous bone marrow transplantation ( BMTor ABMT ) offers a chance for long - term survival in cases of poor- prognosis AML ( Dini et al , 1996 ; Gale et al , 1996 ) .", "label": "", "metadata": {}, "score": "76.24342"}
{"text": "The effect of 9-beta - D - arabinofuranosyl-2-fluoroadenine and 1-beta - D- arabinofuranosylcytosine on the cell cycle phase distribution , topoisomerase II level , mitoxantrone cytotoxicity , and DNA strand break production in K562 human leukemia cells .", "label": "", "metadata": {}, "score": "76.31755"}
{"text": "WHO handbook for reporting results of cancer treatment .WHO Offset Publication , 38 , 1 - 41 .Blood , 60 , 454 - 462 .", "label": "", "metadata": {}, "score": "76.414536"}
{"text": "SEARCH .Search Scope All content Publication titles In this journal In this issue .Abstract .BACKGROUND .This study sought to compare the clinical outcomes of upper versus whole - neck prophylactic irradiation in the treatment of patients with node - negative nasopharyngeal carcinoma ( NPC ) .", "label": "", "metadata": {}, "score": "76.45218"}
{"text": "One patient died in CR from invasive aspergillosis .Keywords : AML , resistant , AML relapse , AML reinduction therapy , AML BMT .Intensive chemotherapy has significantly improved the prognosis of patients with newly diagnosed acute myelogen- ous leukaemia ( AML ) of adults and children .", "label": "", "metadata": {}, "score": "76.5076"}
{"text": "Indolent lymphomas .The standard management of low - grade NHL is controversial and ranges from the ? watch and wait ? approach pioneered at Stanford University to the use of combination regimens containing anthracycline , such as FND ( fludarabine [ Fludara ] , Novantrone [ mitoxantrone ] , dexamethasone ) .", "label": "", "metadata": {}, "score": "76.565865"}
{"text": "Outline .Purpose : To analyze the efficiency of HDR brachytherapy in the treatment of local relapse in previously irradiated tumors of the head and neck with emphasis on acute and late radiation induced morbidity , locoregional control and survival .", "label": "", "metadata": {}, "score": "76.5917"}
{"text": "View at Google Scholar \u00b7 View at Scopus .N. Schoof , F. von Bonin , L. Trumper , and D. Kube , \" HSP90 is essential for Jak - STAT signaling in classical Hodgkin lymphoma cells , \" Cell Communication and Signaling , vol .", "label": "", "metadata": {}, "score": "76.59748"}
{"text": "Farnesyltransferase Inhibitors .Farnesyltransferase inhibitors ( FTIs ) diminish cell proliferation and induce apoptosis in a variety of preclinical models [ 43 ] .The overall response rate was 21 % in RR - HL with 2 complete responses and 2 partial responses .", "label": "", "metadata": {}, "score": "76.59948"}
{"text": "Gianni AM , Siena S , Bregni M , et al : Pro- longed disease - free survival after high - dose se- quential chemo - radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin 's disease .", "label": "", "metadata": {}, "score": "76.67402"}
{"text": "Rituximab .Rituximab can induce responses in 33 % of patients with relapsing aggressive lymphoma of appropriate phenotype ( CD20-positive ) .Ibritumomab .", "label": "", "metadata": {}, "score": "76.83293"}
{"text": "Blood , 89 , 2311 - 2318 .Hiddemann , W. ( 1991 ) Cytosine arabinoside in the treatment of acute myeloid leukemia : the role and place of high - dose regimens .", "label": "", "metadata": {}, "score": "76.89604"}
{"text": "A phase I clinical trial combining the HDAC inhibitor panobinostat with the mTOR inhibitor everolimus is currently enrolling patients with non - Hodgkin 's lymphoma ( NHL ) and HL .", "label": "", "metadata": {}, "score": "76.966"}
{"text": "In order to verify if the technical improvements introduced with IMRT or VMAT have translated into a clinical benefit , we evaluated the clinical outcome of MPM patients treated with chemotherapy , surgery and 3DCRT or HCRT at our institution .", "label": "", "metadata": {}, "score": "77.04719"}
{"text": "The purine analogs , such as fludarabine and cladribine ( 2- CdA [ Leustatin ] ) , have significant antitumor activity in low - grade NHL and are being studied in combination regimens .", "label": "", "metadata": {}, "score": "77.070404"}
{"text": "Moreover , the newer regimens were more toxic and expensive .A recently reported investigation suggests an advantage with the addition of etoposide to the CHOP regimen ( CHOEP ) given every 2 or 3 weeks .", "label": "", "metadata": {}, "score": "77.17296"}
{"text": "Planning and dose calculation was performed on the Eclipse planning system ( Varian Medical Systems , Palo Alto , CA ) for a linear accelerator ( Clinac 6EX or Trilogy , Varian Medical Systems ) .", "label": "", "metadata": {}, "score": "77.35813"}
{"text": "Journal of Pediatric Hematology and Oncology , 19 , 304 - 308 .1998 Blackwell Science Ltd , British Journal of Haematology 102 : 647 - 655 654 G. Fleischhack et al .", "label": "", "metadata": {}, "score": "77.484085"}
{"text": "The upper and lower neck was divided at the lower edge of the cricoid bone .Radiotherapy .Patients were treated by either conventional or intensity - modulated radiotherapy ( IMRT ) .", "label": "", "metadata": {}, "score": "77.567856"}
{"text": "The introduction of highly conformal radiotherapy ( HCRT ) technique improved dose delivery and target coverage in comparison to 3-dimensional conformal radiotherapy ( 3DCRT ) .", "label": "", "metadata": {}, "score": "77.78785"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. de Wit and D. K. Hossfeld , \" Late relapse following Hodgkin 's diseaseSp\u00e4trezidive nach Morbus Hodgkin , \" Deutsche Medizinische Wochenschrift , vol .", "label": "", "metadata": {}, "score": "77.818634"}
{"text": "Toxicity was compared using the chi - square test .Fisher 's exact test was used whenever a small sample size existed .SPSS version 17.0 software ( SPSS Inc. , Chicago , Ill ) was used for the statistical analysis .", "label": "", "metadata": {}, "score": "77.82027"}
{"text": "Stage I / IIA bulky .Chemotherapy + adjuvant radiotherapy .For patients with bulky disease , a minimum of six cycles of CHOP is typically administered .", "label": "", "metadata": {}, "score": "77.88163"}
{"text": "Monoclonal Antibodies .The monoclonal antibodies that have been studied in relapsed / refractory HL target CD30 , CD20 , and CD25 .Targeting CD30 : Brentuximab Vedotin .", "label": "", "metadata": {}, "score": "77.98127"}
{"text": "Bone Marrow Transplantation , 18 , ( Suppl .Journal of Clinical Oncology , 15 , 2780 - 2785 .DiRaimondo , F. , Giustolisi , Kantarjian , H. , Robertson , L.B. & Keating , M.J. ( 1993 ) Auto- immune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine .", "label": "", "metadata": {}, "score": "77.99616"}
{"text": "High dose chemotherapy ( HDCT ) with peripheral stem cell support has been evaluated for the treatment of many high risk paediatric tumours [ 8 - 11 ] .", "label": "", "metadata": {}, "score": "78.00799"}
{"text": "Conflict of Interests .The authors have no conflict of interests to declare .References .20 , no . 2 , pp .467 - 475 , 2002 .", "label": "", "metadata": {}, "score": "78.10199"}
{"text": "Unfortunately , the majority of deaths of patients in very late relapse are related to treatment complications while deaths due to HL are unusual .Future treatment regimens for HL , including very late relapse , need to be designed to minimize complications .", "label": "", "metadata": {}, "score": "78.14397"}
{"text": "The main toxicity of the IDA - FLAG regimen was a long- term myelosuppression associated with a high incidence of infections ( 76 % of courses ) .", "label": "", "metadata": {}, "score": "78.17005"}
{"text": "Nonhaematological according to the World Health Organization ( W.H.O. ) grading system and were tabulated for all patients ( World Health Organisation , 1979 ) .", "label": "", "metadata": {}, "score": "78.28206"}
{"text": "It has long been documented that metastases to the cervical lymph nodes from NPC follow an orderly pattern , from the upper neck inferiorly to the lower neck and then the supraclavicular fossa .", "label": "", "metadata": {}, "score": "78.45722"}
{"text": "The pattern of pleural dissemination , infiltrative growth and the manipulations within the chest cavity during surgery place the entire ipsilateral chest wall at high risk for post - surgical relapse , especially at the diaphragm insertion , the pericardium , mediastinum and bronchial stump .", "label": "", "metadata": {}, "score": "78.5197"}
{"text": "In recent years radiotherapy has made enormous technical advances .More sophisticated highly conformal radiation techniques ( HCRT ) such as IMRT or rotational RT ( VMAT ) have become available and substituted for the older 3DCRT technique .", "label": "", "metadata": {}, "score": "78.639465"}
{"text": "doi : 10.1002/cncr.28201 .Author Information .Department of Radiation Oncology , Jiangxi Cancer Hospital , Nanchang , China .Department of Oncology , Jiangxi Maternity and Child Health Care Hospital , Nanchang , China .", "label": "", "metadata": {}, "score": "78.83034"}
{"text": "No patient developed a tumour lysis syndrome before , during or after therapy .Treatment .The FLAG course was a combination chemotherapy of fludarabine , cytarabine and G - CSF as in the IDA - FLAG regimen but without idarubicin .", "label": "", "metadata": {}, "score": "79.640564"}
{"text": "In recent years , the need for extensive surgery has been questioned , and less radical surgery has been advocated such as pleurectomy / decortication .", "label": "", "metadata": {}, "score": "79.91306"}
{"text": "Significant activity for fludarabine and 2-chlorodeoxyadenosine has been demonstrated in relapsed low - grade lymphomas , both as single agents and in combination with other drugs .", "label": "", "metadata": {}, "score": "80.02243"}
{"text": "The urgent research question , if postoperative radiotherapy impacts on overall survival after EPP , is addressed by a randomized study currently conducted in Switzerland , SAKK 1704 .", "label": "", "metadata": {}, "score": "80.04588"}
{"text": "No case of sinusoidal obstruction syndrome occurred .These results warrant a prospective trial of GO in a larger population of children with AML .\u00a9 2006 Warszawski et al .", "label": "", "metadata": {}, "score": "80.17369"}
{"text": "Goodman , E.R. , Fiedor , P.S. , Fein , S. , Athan , E. & Hardy , M.A. ( 1996 ) Fludarabine phosphate : a DNA synthesis inhibitor with potent immunosuppressive activity and minimal clinical toxicity .", "label": "", "metadata": {}, "score": "80.24132"}
{"text": "Sometimes , an aggressive lymphoma may relapse as a small cell ( indolent ) lymphoma .Such a situation occurs with indolent lymphoma in the bone marrow and with aggressive lymphoma in a nodal site .", "label": "", "metadata": {}, "score": "80.37931"}
{"text": "The mainstay of treatment is surgery consisting of either pleurectomy / decortication ( PD ) or radical extrapleural pneumonectomy ( EPP ) in combination with cisplatin / pemetrexed and , in selected cases , postoperative radiotherapy [ 2 - 5 ] .", "label": "", "metadata": {}, "score": "80.82513"}
{"text": "Benefits .Alkylating agents .For relapse that remains low grade , chemotherapy with single alkylating agents ( often given orally ) or with combinations such as cyclophosphamide , vincristine , and prednisone is often used .", "label": "", "metadata": {}, "score": "81.305504"}
{"text": "Purine analogues such as fludarabine or cladribine produce long - term T - helper - cell depletion involving a high risk of opportunistic infections ( Goodman et al , 1996 ) .", "label": "", "metadata": {}, "score": "81.332504"}
{"text": "Single - agent chemotherapy .( chlorambucil [ Leukeran ] ( daily dose , 0.1 - 0.2 mg / kg ) or cyclophosphamide ( 1.5 - 2.5 mg / kg ) with or without prednisone .", "label": "", "metadata": {}, "score": "81.92396"}
{"text": "Pulmonary infections were the main nonhaematological toxicity .One patient died in CR from invasive aspergillosis .Full - text .A phase II trial was designed to explore the potential feasibility and efficacy of a reinduction therapy consistingof fludarabine , granulocyte colony stimulating factor ( G - CSF ) for acute myelogenous leukaemia ( AML ) patients with poor prognosis .", "label": "", "metadata": {}, "score": "82.0446"}
{"text": "The initial recommendation of a second IDA - FLAG course was changed for toxicity reasons .Thereafter idarubicin was omitted and only the FLAG course was allowed as second or third course .", "label": "", "metadata": {}, "score": "83.24573"}
{"text": "The French osteosarcoma group is engaged in a randomized study to compare the benefit of this treatment to conventional chemotherapy in relapsed osteosarcomas .Conflict of Interests .", "label": "", "metadata": {}, "score": "83.30086"}
{"text": "4 , pp .1244 - 1253 , 1999 .View at Google Scholar \u00b7 View at Scopus .61 , no .4 , pp .", "label": "", "metadata": {}, "score": "83.46028"}
{"text": "Center for Clinical Research , University of Zurich .Department of Radiotherapy and Radiation Oncology , Dessau Municipal Hospital .References .Tsao AS , Wistuba I , Roth JA , Kindler HL : Malignant pleural mesothelioma .", "label": "", "metadata": {}, "score": "83.48685"}
{"text": "Future clinical studies are required to define the role of radiotherapy in combination with lung sparing surgery .Conclusions .In summary , the use of HCRT for treatment of patients with MPM after EPP is likely to improve local control rates .", "label": "", "metadata": {}, "score": "84.01141"}
{"text": "Kaplan - Meier estimate of event - free survival ( EFS ) probability .Fig 3 .Kaplan - Meier estimate of progression - free survival ( PFS ) probability .", "label": "", "metadata": {}, "score": "84.24916"}
{"text": "4 , pp .1025 - 1032 , 2000 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .48 , no . 7 , pp .", "label": "", "metadata": {}, "score": "84.28825"}
{"text": "A phase II trial evaluated the clinical activity and toxicity of everolimus in patients with heavily pretreated RR - HL ( median of 6 prior therapies and 84 % had prior HDCT - ASCT ) .", "label": "", "metadata": {}, "score": "84.42462"}
{"text": "Radiation in a prior radiation field should be considered if tissue tolerance allows ; however there is little information to support this .Second Autologous Transplant .", "label": "", "metadata": {}, "score": "84.46995"}
{"text": "B pathway .The cancer and leukemia group B ( CALGB ) conducted phase II clinical trials ( CALGB 50206 ) evaluating bortezomib monotherapy in RR - HL .", "label": "", "metadata": {}, "score": "85.106384"}
{"text": "Targeting CD20 : Rituximab .CD20 antigen is highly expressed by the reactive B cells in the microenvironment of HL [ 21 ] .In a pilot study , 22 patients with relapsed classical HL were treated with six weekly doses of rituximab .", "label": "", "metadata": {}, "score": "85.38866"}
{"text": "No other uses without permission .Copyright \u00a9 2004 American Society of Clinical Oncology .All rights reserved .Page 7 .Long - term follow - up is important because our data reveal that 38 % of deaths occurred between 4 and 12 years after transplantation , with 15 % of our patients relapsing beyond2years .", "label": "", "metadata": {}, "score": "85.44828"}
{"text": "Testicular lymphoma : orchiectomy followed by combination chemotherapy with an anthracycline - containing regimen has improved the results of therapy for primary testicular lymphoma .Because of the increased risk of recurrence in the CNS and opposite testis , intrathecal chemotherapy ( though controversial because relapse is primarly CNS parenchymal disease ) and irradiation to the contralateral testis are recommended .", "label": "", "metadata": {}, "score": "85.75378"}
{"text": "Regulatory approval was given by the participating institutions of Germanyand Austria .The data of the patients were collected and documented in a database at the University of Bonn .", "label": "", "metadata": {}, "score": "85.913414"}
{"text": "Mammalian Target of Rapamycin Inhibitors .The phosphatidylinositol 3-kinase ( PI3 K ) Akt / mTOR signalling pathway is one of the most aberrantly activated survival pathways in cancer , making it an important target for drug development [ 37 ] .", "label": "", "metadata": {}, "score": "85.93365"}
{"text": "Based on our data , the IDA - FLAG regimen with IDA - FLAG as reinduction course and FLAG as consolidation therapy is an effective therapy prior to allogeneic and autologous BMT or PBSCT .", "label": "", "metadata": {}, "score": "86.17442"}
{"text": "71 , no . 7 - 8 , pp .689 - 695 , 1987 .View at Google Scholar \u00b7 View at Scopus . 7 , no . 2 , pp .", "label": "", "metadata": {}, "score": "86.34691"}
{"text": "Bone marrow transplantation .Bone marrow transplantation is the treatment of choice for patients whose lymphoma has relapsed .Preparative drug regimens have varied ; some investigators also use total - body irradiation .", "label": "", "metadata": {}, "score": "86.78814"}
{"text": "Address reprint requests to Sarah S. Donaldson , MD , Department of Radia- tion Oncology , Stanford University Medical Center , 875 Blake Wilbur Drive , Stanford , CA 94305 - 5847 ; e - mail : sarah@reyes.stanford.edu .", "label": "", "metadata": {}, "score": "86.84879"}
{"text": "Kaplan - Meier estimate of overall survival ( OS ) probability .For personal use only .No other uses without permission .Copyright \u00a9 2004 American Society of Clinical Oncology .", "label": "", "metadata": {}, "score": "87.2115"}
{"text": "Prophylactic upper neck irradiation is sufficient for patients with node - negative NPC .Cancer 2013;119:3170 - 3176 .\u00a9 2013 American Cancer Society .INTRODUCTION .", "label": "", "metadata": {}, "score": "87.539474"}
{"text": "Rituximab ( Rituxan ) .Rituximab ( Rituxan ) , either alone or combined with these agents ( eg , CVP or CHOP ) , is being investigated .", "label": "", "metadata": {}, "score": "87.71459"}
{"text": "320 - 324 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .12 , no . 2 , pp .", "label": "", "metadata": {}, "score": "87.919586"}
{"text": "In severely immunocompromised patients , this fungus may cause disseminated disease and is often confused with Aspergillus , as the two pathogens have similar histopathological appearances .", "label": "", "metadata": {}, "score": "88.21965"}
{"text": "One course of IDA - FLAG in the patient suffering from a CMML in leukaemic transformation had to be interrupted on day 3 due to progressive respiratory failure .", "label": "", "metadata": {}, "score": "88.715454"}
{"text": "Further improvement of trimodal or systemic therapy is required to tackle the high risk of distant recurrences .Declarations .Acknowledgement .We thank Sarah Verlaan for thorough revision with regard to language .", "label": "", "metadata": {}, "score": "88.78727"}
{"text": "12 , pp .1798 - 1804 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .104 , no .", "label": "", "metadata": {}, "score": "89.282196"}
{"text": "Mesothelioma Radiation therapy Extrapleural pneumonectomy Volumetric modulated arc therapy Intensity modulated radiotherapy Multimodal therapy .Introduction .Malignant pleural mesothelioma ( MPM ) is a rare and aggressive malignancy associated with poor prognosis .", "label": "", "metadata": {}, "score": "89.63395"}
{"text": "Further studies of both single - agent bendamustine and in combination with any other chemotherapy are warranted in RR - HL patients .Novel Agents .", "label": "", "metadata": {}, "score": "89.88359"}
{"text": "10.1016/j.ijrobp.2007.06.075 View Article PubMed .Int J Radiat Oncol Biol Phys 2010 , 77 : 942 - 949 .10.1016/j.ijrobp.2009.09.053 View Article PubMed .", "label": "", "metadata": {}, "score": "90.361206"}
{"text": "\u00a9 Krayenbuehl et al . ; licensee BioMed Central Ltd. 2014 .This article is published under license to BioMed Central Ltd. IDA - FLAG ( idarubicin , fludarabine , cytarabine , G - CSF ) , an effective remission - induction therapy for poor prognosis AML of childhood or autologous bone marrow transplantation : experiences of a phase II trial .", "label": "", "metadata": {}, "score": "90.97972"}
{"text": "22 , no .5 , pp .1228 - 1235 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "91.34294"}
{"text": "\" [ Show abstract ] [ Hide abstract ] ABSTRACT : Gemtuzumab ozogamicin ( GO ) is a cytotoxic anti - CD33 monoclonal antibody that has given promising preliminary results in adult myeloid CD33 + AML .", "label": "", "metadata": {}, "score": "91.40948"}
{"text": "18 , pp .4882 - 4889 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus Abstract .Background .", "label": "", "metadata": {}, "score": "91.68413"}
{"text": "CD25 , an interleukin-2 receptor ( IL-2R ) alpha subunit , is expressed in adult T - cell leukaemia , cutaneous T - cell lymphoma , ALCL , and hairy cell leukaemia and on Reed - Sternberg and associated polyclonal T - cells in HL .", "label": "", "metadata": {}, "score": "93.79111"}
{"text": "Chemotherapy .CHOP + rituximab .The addition of rituximab to CHOP has become routine in the United States and is also being employed with combined - modality therapy .", "label": "", "metadata": {}, "score": "94.10443"}
{"text": "Heat Shock Protein 90 Inhibitors .Heat shock proteins are cellular chaperone proteins required for essential housekeeping .Similarly HSP90 has been found to be overexpressed in primary and cultured HL cells [ 40 ] .", "label": "", "metadata": {}, "score": "94.12731"}
{"text": "Lancet 341:1051 - 1054 , 1993 55 .For personal use only .No other uses without permission .Copyright \u00a9 2004 American Society of Clinical Oncology .", "label": "", "metadata": {}, "score": "94.13182"}
{"text": "24 , no .4 , pp .250 - 255 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "94.36815"}
{"text": "Histone Deacetylase Inhibitors .Histone deacetylases ( HDACs ) are crucial in cell proliferation , apoptosis , angiogenesis , and immune regulation .Their alteration has been found to be associated with various malignancies including HL .", "label": "", "metadata": {}, "score": "94.79608"}
{"text": "For personal use only .No other uses without permission .Copyright \u00a9 2004 American Society of Clinical Oncology .All rights reserved .Page 3 . time of AHSCT , all patients had previously received conventional multiagent chemotherapy .", "label": "", "metadata": {}, "score": "94.79982"}
{"text": "Allogeneic stem cell transplant is the only strategy that allows achieving long - time survival .For patients who are not candidates for allogeneic stem cell transplant , single - agent or combination chemotherapy with gemcitabine or vinorelbine may be tried with some beneficial effects .", "label": "", "metadata": {}, "score": "94.864716"}
{"text": "The soft tissues , part of the thyroid gland , carotid , and apex of the lungs were inevitably irradiated when the lower neck region was treated , which could damage these tissues .", "label": "", "metadata": {}, "score": "94.989395"}
{"text": "933 - 937 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .17 , no . 1 , pp .", "label": "", "metadata": {}, "score": "96.32207"}
{"text": "Bendamustine is a mechlorethamine derivative with alkylating and antimetabolite properties .It showed marked antiproliferative and proapoptotic effects on HL cell lines [ 30 ] .", "label": "", "metadata": {}, "score": "99.45061"}
{"text": "cyclophosphamide + doxorubicin + vincristine + prednisone .CHOP - B .More intensive combination , CHOP - B ( bleomycin [ Blenoxane ] ) , is reported not to have any advantage vs single - agent cyclophosphamide .", "label": "", "metadata": {}, "score": "99.643295"}
{"text": "1998 Blackwell Science Ltd Correspondence : Paediatric Haematology / Oncology , University Bonn , Adenauerallee 119 , D-53113 Bonn , Germany .Dr Gudrun Fleischhack , Departmentof .", "label": "", "metadata": {}, "score": "100.05278"}
{"text": "\u00a9 2006 Warszawski et al .Er darf vervielf\u00e4ltigt , verbreitet und \u00f6ffentlich zug\u00e4nglich gemacht werden , vorausgesetzt dass Autor und Quelle genannt werden .Gliederung .", "label": "", "metadata": {}, "score": "100.38938"}
{"text": "10.1016/S0003 - 4975(96)01228 - 3 View Article PubMed .Ann Thorac Surg 2007 , 84 : 1685 - 1693 .10.1016/j.athoracsur.2007.04.076 View Article PubMed .", "label": "", "metadata": {}, "score": "101.37282"}
{"text": "CHOP .The classic regimen is CHOP .Randomized comparisons have failed to show an advantage of the third - generation regimens over CHOP .Benefits : .", "label": "", "metadata": {}, "score": "102.97635"}
{"text": "1 Hematology Department , DAP , University of Bari , Piazza G.Cesare 11 , 70124 Bari , Italy 2 Hematology Department , Cardinal G. Panico Hospital , Tricase , 73039 LE , Italy .", "label": "", "metadata": {}, "score": "104.0604"}
{"text": "No other uses without permission .Copyright \u00a9 2004 American Society of Clinical Oncology .All rights reserved .Page 2 .Wepresentananalysisoftreatment - relatedtoxicityandprog- nosticimplicationsofvariousdiseasecharacteristics .", "label": "", "metadata": {}, "score": "105.999084"}
{"text": "No other uses without permission .Copyright \u00a9 2004 American Society of Clinical Oncology .All rights reserved .Page 8 .Critical appraisal of curative potential .", "label": "", "metadata": {}, "score": "106.273575"}
{"text": "Academic Editors : R. A. Abrams and H. Al - Ali .Copyright \u00a9 2014 Nida Iqbal et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "112.77611"}
{"text": "The impact factor represents a rough estimation of the journal 's impact factor and does not reflect the actual current impact factor .Publisher conditions are provided by RoMEO .", "label": "", "metadata": {}, "score": "115.40703"}
{"text": "For personal use only .No other uses without permission .Copyright \u00a9 2004 American Society of Clinical Oncology .All rights reserved .Data provided are for informational purposes only .", "label": "", "metadata": {}, "score": "115.91883"}
{"text": "Academic Editor : J. F. San Miguel .Copyright \u00a9 2011Francesco Gaudio et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "123.35803"}
{"text": "Copyright \u00a9 2014 Perrine Marec - Berard et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "127.35522"}
